<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName archivearticle3.dtd?><?SourceDTD.Version 3.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Immunology</journal-id><journal-id journal-id-type="iso-abbrev">Immunology</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1365-2567</journal-id><journal-id journal-id-type="publisher-id">IMM</journal-id><journal-title-group><journal-title>Immunology</journal-title></journal-title-group><issn pub-type="ppub">0019-2805</issn><issn pub-type="epub">1365-2567</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6283655</article-id><article-id pub-id-type="doi">10.1111/imm.13012</article-id><article-id pub-id-type="publisher-id">IMM13012</article-id><article-categories><subj-group subj-group-type="overline"><subject>Review Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Review Articles</subject></subj-group></article-categories><title-group><article-title>Systems vaccinology and big data in the vaccine development chain</article-title><alt-title alt-title-type="left-running-head">R. H. M. Raeven <italic>et al</italic>.</alt-title></title-group><contrib-group><contrib id="imm13012-cr-0001" contrib-type="author" corresp="yes"><name><surname>Raeven</surname><given-names>Ren&#x000e9; H. M.</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1063-271X</contrib-id><address><email>rene.raeven@intravacc.nl</email></address><xref ref-type="aff" rid="imm13012-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="imm13012-cr-0002" contrib-type="author"><name><surname>van Riet</surname><given-names>Elly</given-names></name><xref ref-type="aff" rid="imm13012-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="imm13012-cr-0003" contrib-type="author"><name><surname>Meiring</surname><given-names>Hugo D.</given-names></name><xref ref-type="aff" rid="imm13012-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="imm13012-cr-0004" contrib-type="author"><name><surname>Metz</surname><given-names>Bernard</given-names></name><xref ref-type="aff" rid="imm13012-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="imm13012-cr-0005" contrib-type="author"><name><surname>Kersten</surname><given-names>Gideon F. A.</given-names></name><xref ref-type="aff" rid="imm13012-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="imm13012-aff-0002">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="imm13012-aff-0001">
<label><sup>1</sup></label>
<institution>Intravacc (Institute for Translational Vaccinology)</institution>
<named-content content-type="city">Bilthoven</named-content>
<country country="NL">The Netherlands</country>
</aff><aff id="imm13012-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Leiden Academic Center for Drug Research</named-content>
<named-content content-type="organisation-division">Division of Biotherapeutics</named-content>
<institution>Leiden University</institution>
<named-content content-type="city">Leiden</named-content>
<country country="NL">The Netherlands</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label>
Correspondence: Ren&#x000e9; H. M. Raeven, Intravacc (Institute for Translational Vaccinology), Antonie van Leeuwenhoeklaan 9, P.O. BOX 450, 3720 AL Bilthoven, The Netherlands. Email: <email>rene.raeven@intravacc.nl</email><break/>
Senior author: All authors are equal senior authors.<break/></corresp></author-notes><pub-date pub-type="epub"><day>13</day><month>11</month><year>2018</year></pub-date><pub-date pub-type="ppub"><month>1</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>13</day><month>11</month><year>2018</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>156</volume><issue>1</issue><issue-id pub-id-type="doi">10.1111/imm.2019.156.issue-1</issue-id><fpage>33</fpage><lpage>46</lpage><history><date date-type="received"><day>16</day><month>7</month><year>2018</year></date><date date-type="accepted"><day>03</day><month>10</month><year>2018</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2019 John Wiley & Sons Ltd <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2018 The Authors. <italic>Immunology</italic> Published by John Wiley &#x00026; Sons Ltd.</copyright-statement><license license-type="creativeCommonsBy-nc"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:IMM-156-33.pdf"/><abstract id="imm13012-abs-0001"><title>Summary</title><p>Systems vaccinology has proven a fascinating development in the last decade. Where traditionally vaccine development has been dominated by trial and error, systems vaccinology is a tool that provides novel and comprehensive understanding if properly used. Data sets retrieved from systems&#x02010;based studies endorse rational design and effective development of safe and efficacious vaccines. In this review we first describe different omics&#x02010;techniques that form the pillars of systems vaccinology. In the second part, the application of systems vaccinology in the different stages of vaccine development is described. Overall, this review shows that systems vaccinology has become an important tool anywhere in the vaccine development chain.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="imm13012-kwd-0001">bioinformatics</kwd><kwd id="imm13012-kwd-0002">proteomics</kwd><kwd id="imm13012-kwd-0003">T&#x02010;cell</kwd><kwd id="imm13012-kwd-0004">transcriptomics</kwd><kwd id="imm13012-kwd-0005">vaccination</kwd></kwd-group><counts><fig-count count="2"/><table-count count="2"/><page-count count="14"/><word-count count="12161"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>imm13012</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>January 2019</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.5.3 mode:remove_FC converted:06.12.2018</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="imm13012-sec-0001"><title>Introduction</title><p>There are many effective vaccines available to protect humans against infectious diseases. However, the development of vaccines against &#x02018;difficult&#x02019; pathogens remains challenging. For example, vaccines against human immunodeficiency virus (HIV) and respiratory syncytial virus (RSV) are still under development. Furthermore, some existing vaccines require improved efficacy, e.g. vaccines against <italic>Bordetella pertussis</italic>, influenza viruses, <italic>Mycobacterium tuberculosis</italic> and <italic>Plasmodium</italic> species causing malaria. In addition, new infectious diseases such as severe acute respiratory syndrome and Ebola virus disease will continue to emerge, which require new vaccines to prevent epidemics. Also, therapeutic vaccines against non&#x02010;infectious diseases, such as cancer, are needed. The lack of in&#x02010;depth knowledge of the pathogen and requirements for protective immunity often hamper development.<xref rid="imm13012-bib-0001" ref-type="ref">1</xref> Application of systems biology during the development of vaccines, or systems vaccinology, can be an important tool to enhance insight into immune responses induced by (candidate) vaccines or identification of (early) correlates of protection.<xref rid="imm13012-bib-0002" ref-type="ref">2</xref>, <xref rid="imm13012-bib-0003" ref-type="ref">3</xref> Alan Aderem defined systems biology as a &#x02018;comprehensive quantitative analysis of the manner in which all the components of a biological system interact functionally over time and space that is executed by an interdisciplinary team of investigators.&#x02019;<xref rid="imm13012-bib-0004" ref-type="ref">4</xref> This definition can readily be applied to study the responses to vaccination. Systems&#x02010;based approaches are often labeled unbiased and broad (sometimes even the word &#x02018;holistic&#x02019; is used). However, that is only true to a certain extent, as defining a research objective is already introducing bias. Often only a few analytical techniques are used (as described in the next section) to address the objectives (Fig. <xref rid="imm13012-fig-0001" ref-type="fig">1</xref>). Usually, there are also limitations in availability of materials. For example, in preclinical studies using mice the amount of blood that can be collected is very limited, whereas in clinical studies mainly body fluids can be used, although biopsies and mucosal lavages are sometimes available. Also, time is an essential parameter of systems vaccinology for studying kinetics and cause&#x02013;effect relations, but repeated sampling is limited in humans. In this review, we describe current developments of the techniques that form the pillars of systems vaccinology and discuss the implementation of systems vaccinology in the vaccine research and development chain.</p><fig fig-type="Figure" xml:lang="en" id="imm13012-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Systems vaccinology approach in a pre&#x02010;clinical setting. A biological system can range from a single cell to the complete human body consisting of different levels such as genes, proteins, cells, tissues and organs that interact with each other. The biological processes in these levels have distinct time&#x02010; and space&#x02010;resolved kinetics. Information on the immune status can be acquired by analysis at the molecular level of the actors (i.e. gene expression, protein synthesis, lipid secretion and production of metabolites), or by determining the changes in cellular composition and morphology. To study the relationship and interaction between all distinct levels of a biological system, a comprehensive approach is required, using multiple analytical techniques. Data, preferably obtained during a time course of the same subject, are combined for further analysis. Network analysis (e.g. Cytoscape) is performed to determine co&#x02010;expression profiles, indicating interdependence. Functional analysis is executed in public databases, e.g. DAVID (<ext-link ext-link-type="uri" xlink:href="http://www.david.ncifcrf.gov">http://www.david.ncifcrf.gov</ext-link>), STRING (<ext-link ext-link-type="uri" xlink:href="http://www.string-db.org">http://www.string-db.org</ext-link>), BioGPS (<ext-link ext-link-type="uri" xlink:href="http://www.biogps.org">http://www.biogps.org</ext-link>), and Interferome (<ext-link ext-link-type="uri" xlink:href="http://www.interferome.org">http://www.interferome.org</ext-link>). Combined data form a response profile for a vaccine. Vaccine profiles can be compared with other vaccine or infection profiles and used for multiple applications as mentioned in Table <xref rid="imm13012-tbl-0001" ref-type="table">1</xref>.</p></caption><graphic id="nlm-graphic-3" xlink:href="IMM-156-33-g001"/></fig></sec><sec id="imm13012-sec-0002"><title>Systems vaccinology techniques</title><p>Twenty years ago, Rino Rappuoli and co&#x02010;workers introduced reverse vaccinology, a genome&#x02010;based method to identify new leads with strong antibody responses.<xref rid="imm13012-bib-0005" ref-type="ref">5</xref> However, the role of immunogens is currently studied in conjunction with other factors, such as adjuvants and antigen delivery, as these influence immune responses and induction of immunological memory that are key for vaccine efficacy. Systems vaccinology addresses these aspects in order to understand why some vaccines function properly whereas other vaccines do not. In this section, the most important and widely used techniques applied in different levels of systems vaccinology are described. An overview of these techniques and applications thereof that are used for the systems vaccinology&#x02010;based approach, are listed in Table <xref rid="imm13012-tbl-0001" ref-type="table">1</xref>.</p><table-wrap id="imm13012-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>The omics in vaccinology</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Omics type</th><th align="left" valign="top" rowspan="1" colspan="1">Application</th><th align="left" valign="top" rowspan="1" colspan="1">Technology</th><th align="left" valign="top" rowspan="1" colspan="1">Literature</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Genomics</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0142" ref-type="ref">142</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Single&#x02010;nucleotide polymorphism</td><td align="left" rowspan="1" colspan="1">
Restriction fragment length polymorphism (RFLP)<break/>
Microarray analysis<break/>
DNA sequencing
</td><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0143" ref-type="ref">143</xref>
<break/>
<xref rid="imm13012-bib-0144" ref-type="ref">144</xref>, <xref rid="imm13012-bib-0145" ref-type="ref">145</xref>
</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Epigenomics</td><td align="left" rowspan="1" colspan="1">Age&#x02010;related immune responses, vaccine&#x02010;induced memory T&#x02010;cells</td><td align="left" rowspan="1" colspan="1">ChIP&#x02010;seq, DNA methylation</td><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0146" ref-type="ref">146</xref>, <xref rid="imm13012-bib-0147" ref-type="ref">147</xref>, <xref rid="imm13012-bib-0148" ref-type="ref">148</xref>
</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Personal genomics</td><td align="left" rowspan="1" colspan="1">Personalized vaccines</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0149" ref-type="ref">149</xref>, <xref rid="imm13012-bib-0150" ref-type="ref">150</xref>, <xref rid="imm13012-bib-0151" ref-type="ref">151</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Transcriptomics</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0152" ref-type="ref">152</xref>, <xref rid="imm13012-bib-0153" ref-type="ref">153</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Single cell transcriptomics</td><td align="left" rowspan="1" colspan="1">
RNA&#x02010;seq<break/>
CITE&#x02010;seq
</td><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0154" ref-type="ref">154</xref>
<break/>
<xref rid="imm13012-bib-0017" ref-type="ref">17</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Host&#x02013;pathogen interaction</td><td align="left" rowspan="1" colspan="1">RNA&#x02010;seq, Microarray</td><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0155" ref-type="ref">155</xref>, <xref rid="imm13012-bib-0156" ref-type="ref">156</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Infection&#x02010;induced responses</td><td align="left" rowspan="1" colspan="1">RNA&#x02010;seq, Microarray, quantitative polymerase chain reaction (qPCR)</td><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0012" ref-type="ref">12</xref>, <xref rid="imm13012-bib-0157" ref-type="ref">157</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Transcriptional responses by vaccination</td><td align="left" rowspan="1" colspan="1">RNA&#x02010;seq, Microarray, qPCR</td><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0013" ref-type="ref">13</xref>, <xref rid="imm13012-bib-0015" ref-type="ref">15</xref>, <xref rid="imm13012-bib-0116" ref-type="ref">116</xref>, <xref rid="imm13012-bib-0124" ref-type="ref">124</xref>, <xref rid="imm13012-bib-0126" ref-type="ref">126</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<italic>In vivo</italic> analysis of transcriptome</td><td align="left" rowspan="1" colspan="1">Transcriptome <italic>in vivo</italic> analysis (TIVA)</td><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0011" ref-type="ref">11</xref>
</td></tr><tr><td align="left" colspan="4" rowspan="1">Proteomics</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Immunoproteomics</td><td align="left" rowspan="1" colspan="1">
T&#x02010;cell epitope identification<break/>
Antibody specificity (antigen identification)
</td><td align="left" rowspan="1" colspan="1">
Liquid chromatography&#x02010;mass spectrometry (LC&#x02010;MS)<break/>
ELISA, MIA, two&#x02010;dimensional Western blotting + LC&#x02010;MS
</td><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0020" ref-type="ref">20</xref>
<break/>
<xref rid="imm13012-bib-0059" ref-type="ref">59</xref>
</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Interactomics and Ligandomics</td><td align="left" rowspan="1" colspan="1">
B&#x02010;cell epitope mapping<break/>
Antibody epitope identification<break/>
Antigen identification<break/>
Cell&#x02010;to&#x02010;cell signaling
</td><td align="left" rowspan="1" colspan="1">
X&#x02010;ray crystallography<break/>
LC&#x02010;MS (epitope excision/extraction)<break/>
Peptide arrays<break/>
Immunoglobulin sequencing<break/>
Chemical cross&#x02010;linking mass spectrometry (XL&#x02010;MS)
</td><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0158" ref-type="ref">158</xref>
<break/>
<xref rid="imm13012-bib-0159" ref-type="ref">159</xref>, <xref rid="imm13012-bib-0160" ref-type="ref">160</xref>
<break/>
<xref rid="imm13012-bib-0060" ref-type="ref">60</xref>
<break/>
<xref rid="imm13012-bib-0055" ref-type="ref">55</xref>
<break/>
<xref rid="imm13012-bib-0036" ref-type="ref">36</xref>
</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Peptidomics</td><td align="left" rowspan="1" colspan="1">MHC epitope display</td><td align="left" rowspan="1" colspan="1">Mass spectrometry</td><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0161" ref-type="ref">161</xref>
</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Secretomics</td><td align="left" rowspan="1" colspan="1">Chemokine secretion</td><td align="left" rowspan="1" colspan="1">BONCAT</td><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0040" ref-type="ref">40</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Systems serology</td><td align="left" rowspan="1" colspan="1">Antibody level, isotype, subtype, specificity, functionality, glycosylation</td><td align="left" rowspan="1" colspan="1">ELISA, MIA, LC&#x02010;MS, Western blotting</td><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0072" ref-type="ref">72</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Metabolomics</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0047" ref-type="ref">47</xref>
</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Metabolomics</td><td align="left" rowspan="1" colspan="1">
Response to vaccination<break/>
Predictive biomarker discovery
</td><td align="left" rowspan="1" colspan="1">
Gas chromatography&#x02010;Mass spectrometry (GC&#x02010;MS)<break/>
LC&#x02010;MS<break/>
Nuclear magnetic resonance (NMR)
</td><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0046" ref-type="ref">46</xref>, <xref rid="imm13012-bib-0162" ref-type="ref">162</xref>, <xref rid="imm13012-bib-0163" ref-type="ref">163</xref>
</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Lipidomics</td><td align="left" rowspan="1" colspan="1">Biomarker discovery</td><td align="left" rowspan="1" colspan="1">LC&#x02010;MS</td><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0105" ref-type="ref">105</xref>, <xref rid="imm13012-bib-0164" ref-type="ref">164</xref>, <xref rid="imm13012-bib-0165" ref-type="ref">165</xref>
</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Glycomics</td><td align="left" rowspan="1" colspan="1">Mapping antibody glycosylation</td><td align="left" rowspan="1" colspan="1">
Capillary electrophoresis<break/>
LC&#x02010;MS
</td><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0166" ref-type="ref">166</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Cellomics</td><td align="left" rowspan="1" colspan="1">
Mechanism of action,<break/>
Correlates of protection,<break/>
Involved cell types<break/>
B&#x02010;cell and T&#x02010;cell repertoire
</td><td align="left" rowspan="1" colspan="1">
Flow cytometry, ELIspot<break/>
Cytometry by time&#x02010;of&#x02010;flight MS<break/>
High&#x02010;throughput single&#x02010;cell analysis
</td><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0012" ref-type="ref">12</xref>, <xref rid="imm13012-bib-0015" ref-type="ref">15</xref>
<break/>
<xref rid="imm13012-bib-0053" ref-type="ref">53</xref>, <xref rid="imm13012-bib-0054" ref-type="ref">54</xref>, <xref rid="imm13012-bib-0137" ref-type="ref">137</xref>
<break/>
<xref rid="imm13012-bib-0056" ref-type="ref">56</xref>, <xref rid="imm13012-bib-0057" ref-type="ref">57</xref>, <xref rid="imm13012-bib-0058" ref-type="ref">58</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Microbiomics</td><td align="left" rowspan="1" colspan="1">
Vaccine optimization<break/>
Environmental effects<break/>
Host&#x02010;interaction
</td><td align="left" rowspan="1" colspan="1">Next&#x02010;generation sequencing</td><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0167" ref-type="ref">167</xref>, <xref rid="imm13012-bib-0168" ref-type="ref">168</xref>, <xref rid="imm13012-bib-0169" ref-type="ref">169</xref>, <xref rid="imm13012-bib-0170" ref-type="ref">170</xref>, <xref rid="imm13012-bib-0171" ref-type="ref">171</xref>, <xref rid="imm13012-bib-0172" ref-type="ref">172</xref>, <xref rid="imm13012-bib-0173" ref-type="ref">173</xref>, <xref rid="imm13012-bib-0174" ref-type="ref">174</xref>
</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><sec id="imm13012-sec-0003"><title>Transcriptomics</title><p>For decades, RNA analysis has been applied to study vaccine&#x02010;induced responses<xref rid="imm13012-bib-0006" ref-type="ref">6</xref> and has evolved from (quantitative) polymerase chain reaction to high&#x02010;throughput methods like microarrays and next&#x02010;generation sequencing (RNAseq). The applications range from assessing transcriptional profiles in whole tissues and blood to purified cell populations<xref rid="imm13012-bib-0007" ref-type="ref">7</xref>, <xref rid="imm13012-bib-0008" ref-type="ref">8</xref> and, more recently, even single cells.<xref rid="imm13012-bib-0009" ref-type="ref">9</xref>, <xref rid="imm13012-bib-0010" ref-type="ref">10</xref> In contrast to conventional transcriptome analysis that results in loss of tissue or cells, transcriptome <italic>in vivo</italic> analysis allows us to monitor mRNA expression <italic>in situ</italic> in live cells or animals.<xref rid="imm13012-bib-0011" ref-type="ref">11</xref> Transcriptomics of the complete genome is unbiased, relatively straightforward and is offered as a service by many contract laboratories. Gene expression levels and kinetics provide information on involvement of genes following immunization.<xref rid="imm13012-bib-0012" ref-type="ref">12</xref>, <xref rid="imm13012-bib-0013" ref-type="ref">13</xref>, <xref rid="imm13012-bib-0014" ref-type="ref">14</xref>, <xref rid="imm13012-bib-0015" ref-type="ref">15</xref> However, mRNA is often not an effector molecule in itself, but needs translation into protein and mRNA levels often do not correlate with protein content. One study reported that in mice, under those conditions, only 27% of the mRNA transcript correlates with protein expression.<xref rid="imm13012-bib-0016" ref-type="ref">16</xref> To that end, transcriptomic profiling in vaccine research serves as an excellent tool to find potential markers of vaccine&#x02010;induced responses that subsequently need to be confirmed on protein or cellular level. Novel methods such as cellular indexing of transcriptomes and epitopes by sequencing (CITE&#x02010;seq) try to overcome this translational challenge by combining in parallel the targeting of single cells with protein markers with unbiased transcriptome profiling to obtain more specific information on gene expression in cellular phenotypes than RNA&#x02010;seq in the complete tissue.<xref rid="imm13012-bib-0017" ref-type="ref">17</xref> In addition to mRNA profiles, investigating the role of non&#x02010;coding microRNAs becomes relevant given their role in immunology.<xref rid="imm13012-bib-0018" ref-type="ref">18</xref>
</p></sec><sec id="imm13012-sec-0004"><title>Proteomics</title><p>Contrary to the transcriptome, the proteome encompasses the effectors that exert and control the immune response. Receptors, ligands, enzymes, hormones and even structural proteins detect foreign substances, determine the identity of cells and communicate messages between cells and tissues. Profiling the subset of proteins and peptides involved in the immune response (termed immunoproteomics)<xref rid="imm13012-bib-0019" ref-type="ref">19</xref> is important to understand how vaccines work. During the last three decades, mass spectrometry (MS) &#x02010;based proteomics has emerged as an essential tool to profile this immunoproteome in terms of protein identification, protein dynamics and protein&#x02013;protein interactions. Hunt <italic>et al</italic>.<xref rid="imm13012-bib-0020" ref-type="ref">20</xref> pioneered the MS&#x02010;based analysis of immunogenic peptides presented by molecules of the major histocompatibility complex (MHC). Since then, many studies have profiled the human leucocyte antigen (HLA) ligand repertoire using immunoprecipitation techniques and subsequent MS&#x02010;based ligand identification to find new antigen leads and to understand the concept of immunogenicity. Apart from targeting infectious diseases,<xref rid="imm13012-bib-0021" ref-type="ref">21</xref>, <xref rid="imm13012-bib-0022" ref-type="ref">22</xref>, <xref rid="imm13012-bib-0023" ref-type="ref">23</xref>, <xref rid="imm13012-bib-0024" ref-type="ref">24</xref> MHC ligandome analysis also is applied in, for example, cancer immunotherapy.<xref rid="imm13012-bib-0025" ref-type="ref">25</xref> Recent studies, however, have shown that the plethora of MHC&#x02010;presented peptides is even more complex than expected, due to the formation of non&#x02010;linear peptide sequences (i.e. splicing variants) of these T&#x02010;cell epitopes as it is estimated that one&#x02010;third of the CD8<sup>+</sup> T&#x02010;cell epitopes is comprised of proteasome&#x02010;generated spliced epitopes.<xref rid="imm13012-bib-0026" ref-type="ref">26</xref>, <xref rid="imm13012-bib-0027" ref-type="ref">27</xref>, <xref rid="imm13012-bib-0028" ref-type="ref">28</xref>, <xref rid="imm13012-bib-0029" ref-type="ref">29</xref>
</p><p>In addition to profiling the T&#x02010;cell epitope repertoire, assessing the antigenic determinants that interact with B&#x02010;cells and antibodies is of high significance in elucidating immune responses in vaccine development and vaccine design.<xref rid="imm13012-bib-0030" ref-type="ref">30</xref>, <xref rid="imm13012-bib-0031" ref-type="ref">31</xref>, <xref rid="imm13012-bib-0032" ref-type="ref">32</xref> Since B&#x02010;cell epitopes are often conformational or even discontinuous, their identification is complex and currently not possible using <italic>in silico</italic> tools. With instrumental improvement of MS and the supporting software tools, MS is now used as a versatile tool to determine B&#x02010;cell epitopes, that is, the areas where antibodies bind. Opuni <italic>et al</italic>.<xref rid="imm13012-bib-0033" ref-type="ref">33</xref> comprehensively reviewed MS&#x02010;based approaches to map B&#x02010;cell epitopes. Antibody&#x02013;antigen binding is just one example of a protein&#x02013;protein interaction. Large&#x02010;scale interaction analysis (interactomics) is rapidly developing to identify any type of protein&#x02013;protein interaction.</p><p>A new class of MS&#x02010;cleavable cross&#x02010;linking reagents has a great potential in interactomics.<xref rid="imm13012-bib-0034" ref-type="ref">34</xref>, <xref rid="imm13012-bib-0035" ref-type="ref">35</xref>, <xref rid="imm13012-bib-0036" ref-type="ref">36</xref> Like all other cross&#x02010;linking reagents, these compounds stabilize transient protein&#x02013;protein interactions by the formation of covalent bonds under physiological conditions. But they also allow for the unambiguous identification of the spatially distributed peptides of the interacting proteins, based on the presence of characteristic reporter ions in the mass spectra that are representative for intramolecular or intermolecular cross&#x02010;links. Liu <italic>et al</italic>. showed a good correlation between protein three&#x02010;dimensional&#x02010;structure data obtained from chemical cross&#x02010;linking MS (XL&#x02010;MS) using MS&#x02010;cleavable reagents and data from cryo&#x02010;electron microscopy (cryo&#x02010;EM) on purified protein assemblies. In addition, they also identified in HeLa cell lysates cross&#x02010;links from protein domains lacking X&#x02010;ray or cryo&#x02010;EM three&#x02010;dimensional&#x02010;structure data,<xref rid="imm13012-bib-0037" ref-type="ref">37</xref> illustrating the great potential of this strategy in identifying protein&#x02013;protein interactions. To detect protein&#x02013;protein interactions by XL&#x02010;MS, it is mandatory that the amino acids in the interaction area are reactive with the cross&#x02010;linker.</p><p>Secreted proteins play an essential role in communication between immune cells. The immune secretome consists of a wide range of cytokines such as tumor necrosis factors, interferons and interleukins. Multiplex immunoassays and ELISA methods target predefined proteins from the secretome, based on cytokine&#x02010;specific antibodies. In contrast, newly developed MS&#x02010;based proteomics methods like BioOrthogonal Non&#x02010;Canonical Amino acid Tagging (BONCAT) can target the full repertoire of secreted proteins, although limited to <italic>in vitro</italic> experiments only. In a BONCAT assay, an amino acid is replaced by an azido&#x02010;containing analogue (e.g. methionine replacement by azidohomoalanine). The azido moiety allows for purification of excreted, low abundance, newly synthesized proteins from cell culture medium by click&#x02010;chemistry using alkyne&#x02010;functionalized beads.<xref rid="imm13012-bib-0038" ref-type="ref">38</xref>, <xref rid="imm13012-bib-0039" ref-type="ref">39</xref> The amino acid modification does not affect the structure and function of the protein, nor does it alter the protein synthesis rate or cell viability.<xref rid="imm13012-bib-0040" ref-type="ref">40</xref>, <xref rid="imm13012-bib-0041" ref-type="ref">41</xref> In combination with multiplexing technologies based on Tandem Mass Tagging (TMT), <italic>N</italic>,<italic>N</italic>&#x02010;dimethyl leucine (DiLeu) tagging or neutron&#x02010;encoded reagents, up to 25 samples can be multiplexed in a single run, for unbiased identification and relative quantification of <italic>de novo</italic>&#x02010;synthesized proteins in the secretome.<xref rid="imm13012-bib-0042" ref-type="ref">42</xref>, <xref rid="imm13012-bib-0043" ref-type="ref">43</xref>
</p><p>Limitations of MS&#x02010;based proteomics lay in the fact that, like transcriptomics, it is dependent on the availability and quality of annotated protein databases, e.g. number of annotated genes or proteins. The sensitivity of the current generation of mass spectrometers is high, but could improve further to reach the levels achieved with, for example, quantitative polymerase chain reaction. However, as described here and by others,<xref rid="imm13012-bib-0044" ref-type="ref">44</xref> MS is currently very useful for the characterization of a wide range of immunological mechanisms in the context of infection and vaccination.</p></sec><sec id="imm13012-sec-0005"><title>Miscellaneous techniques</title><p>The Systems Vaccinology approach is not limited to the common application of transcriptomics and proteomics and novel techniques and applications are more often applied (Table <xref rid="imm13012-tbl-0001" ref-type="table">1</xref>). For example, metabolomics is a high&#x02010;throughput technology to study metabolic pathways in biological systems. The metabolome covers all small molecules and intermediates (usually &#x0003c; 2000 dalton (Da) molecular weight) that are highly dynamic in the catabolic and anabolic processes of cells. In many immunological studies, metabolomics is now an integral part of system vaccinology, to predict biomarkers and to evaluate vaccine efficacy.<xref rid="imm13012-bib-0045" ref-type="ref">45</xref>, <xref rid="imm13012-bib-0046" ref-type="ref">46</xref> Untargeted metabolome analysis requires many different sample preparation procedures and analytical tools to identify all metabolites. Gas chromatography, liquid chromatography, capillary electrophoresis, MS, Fourier transform infrared spectroscopy and nuclear magnetic resonance are frequently used or combined to study the metabolome, although with limited precision and accuracy. Improved accuracy, precision and specificity of these assays can be obtained by using semi&#x02010;targeted or targeted metabolomics strategies if the chemical identities of the analytes are known beforehand.<xref rid="imm13012-bib-0047" ref-type="ref">47</xref>
</p></sec><sec id="imm13012-sec-0006"><title>Humoral and cell&#x02010;mediated responses</title><p>In the context of systems vaccinology, conventional assays that are neither high throughput, nor unbiased, remain necessary to confirm hypotheses. Histology is still the common method to confirm the influx and the location of immune cells in tissues as a result of an infection or immunization. However, visualization of cells in tissue sections continually improves by better immunoimaging techniques<xref rid="imm13012-bib-0048" ref-type="ref">48</xref> such as confocal microscopy. <italic>Ex vivo</italic>, assays such as ELISA and flow cytometry are applied to identify and quantify specific cell subsets as well as their activation state and function (such as cytokine production or proliferation). These immunological techniques for studying these responses have also become more powerful. Flow cytometry equipment has improved, for example, by combining the measurement of the amount of proteins per cell (flow cytometry), with visualization of their localization within the cells (microscopy), so&#x02010;called imaging flow cytometry.<xref rid="imm13012-bib-0049" ref-type="ref">49</xref> Also, more fluorescent labels have become available, increasing the number of markers that can be investigated simultaneously. Multi&#x02010;parameter flow cytometry enables the identification of these specialized, often rare, subsets of cells.<xref rid="imm13012-bib-0050" ref-type="ref">50</xref> For example, innate cells that play a crucial role in pathogen recognition and in influencing the magnitude and direction of adaptive immunity, such as specific subtypes of antigen&#x02010;presenting cells and innate lymphoid cells. With respect to adaptive immune responses, the ability to identify rare subsets mainly focuses on antigen&#x02010;specific B&#x02010;cells<xref rid="imm13012-bib-0051" ref-type="ref">51</xref> and T&#x02010;cells,<xref rid="imm13012-bib-0052" ref-type="ref">52</xref> both circulating and tissue&#x02010;resident cells, and precursors as well as effector and memory cells.<xref rid="imm13012-bib-0007" ref-type="ref">7</xref>, <xref rid="imm13012-bib-0008" ref-type="ref">8</xref> Cytometry by Time&#x02010;of&#x02010;Flight mass spectrometry (CyTOF)<xref rid="imm13012-bib-0053" ref-type="ref">53</xref> uses rare&#x02010;metal isotopes instead of fluorescent labels for labeling, thereby almost abolishing the spectral overlap seen with fluorescent dyes and expanding the number markers that can be measured simultaneously even further. For example, Van Unen <italic>et al</italic>.<xref rid="imm13012-bib-0054" ref-type="ref">54</xref> identified 142 immune subsets in the human mucosal immune system.</p><p>In addition, the opportunity of sorting specific subsets of cells not only as a population, but also as single cells, in combination with high&#x02010;throughput analysis of the isolated cells, added yet another dimension. Lymphocyte epitope specificity necessarily is extremely diverse to fight the wide array of possible pathogens and is accomplished by randomness through several recombinatorial events and additional random changes during lymphocyte ontogeny. For example, the number of different antibodies human B&#x02010;cells can produce, outnumbers the B lymphocytes (~10<sup>11</sup>) in the human body.<xref rid="imm13012-bib-0055" ref-type="ref">55</xref> High&#x02010;throughput single&#x02010;cell analysis enabled detailed interrogation of these broad B&#x02010;cell and T&#x02010;cell repertoires.<xref rid="imm13012-bib-0056" ref-type="ref">56</xref> These techniques also revealed that priming might not always be predictive, as preferential expansion of B&#x02010;cells and T&#x02010;cells also plays an important role.<xref rid="imm13012-bib-0057" ref-type="ref">57</xref> This illustrates that enhanced understanding of lymphocyte responses not only leads to identification of novel early markers for efficacy of vaccines, but is also useful for their evaluation. Hypotheses with respect to B&#x02010;cell and T&#x02010;cell epitopes can be derived from MS&#x02010;based studies as described in the former paragraph. Moreover, current knowledge with respect to HLA specificity has also enabled the prediction of T&#x02010;cell epitopes <italic>in silico</italic>, decreasing the time needed for analysis.<xref rid="imm13012-bib-0058" ref-type="ref">58</xref> As B&#x02010;cell epitopes are often conformational, current knowledge does not yet enable <italic>in silico</italic> predictions to the same extent as for T&#x02010;cells. For B&#x02010;cell epitope analysis of complex multi&#x02010;protein vaccines, antibody&#x02013;antigen binding can be investigated using two&#x02010;dimensional gel electrophoresis with Western blotting to pinpoint immunogenic antigens.<xref rid="imm13012-bib-0059" ref-type="ref">59</xref> Subsequently, peptide arrays can be applied to investigating the immunodominant epitopes of these discovered antigens.<xref rid="imm13012-bib-0060" ref-type="ref">60</xref>
</p><p>The ability to isolate single antibody&#x02010;producing B&#x02010;cells and subsequent DNA sequencing of immunoglobulin genes in high&#x02010;throughput settings (Ig&#x02010;seq) has greatly impacted the depth of understanding with respect to the antibody repertoire.<xref rid="imm13012-bib-0055" ref-type="ref">55</xref> Single&#x02010;cell sorting in combination with B&#x02010;cell cloning has enabled the isolation of specific antibodies able to neutralize pathogens, including rare antigens with characteristics that are of special interest, such as antibodies that are broadly cross&#x02010;reactive among highly variable viruses by binding to conserved regions. This was, for example, found for influenza hemagglutinin (HA) subtypes upon infection as well as vaccination.<xref rid="imm13012-bib-0061" ref-type="ref">61</xref>, <xref rid="imm13012-bib-0062" ref-type="ref">62</xref>, <xref rid="imm13012-bib-0063" ref-type="ref">63</xref>, <xref rid="imm13012-bib-0064" ref-type="ref">64</xref> In general, this has shifted the focus from the most immunogenic epitopes to the more conserved regions. However, it has proved challenging to design vaccines that induce strong responses against these regions. Challenges with respect to design of vaccines inducing such broadly neutralizing antibodies for HIV and influenza virus were extensively reviewed by Corti and Lanzavecchia.<xref rid="imm13012-bib-0065" ref-type="ref">65</xref> For example, other regions might need to be removed or de&#x02010;immunized and the conserved epitopes might not be easily accessible, preventing the vaccine&#x02010;induced antibodies from binding to the natural target. Another point of attention is that a focus on increased immunogenicity should not lead to a decrease in safety. For example, antibodies with long or charged CDR&#x02010;H3 regions enable binding to occluded sites on pathogens and mediate pathogen neutralization but are also more likely to be autoreactive.<xref rid="imm13012-bib-0055" ref-type="ref">55</xref>
</p><p>IgG antibody levels have served as correlates of protection for traditional vaccines,<xref rid="imm13012-bib-0066" ref-type="ref">66</xref> but in the context of systems vaccinology, not only antibody quantity, but also functionality is increasingly investigated. Antibodies may inhibit other functional antibodies or enhance disease by facilitating virus entry into cells. However, non&#x02010;neutralizing antibodies may still be functional and could have more impact on protection from disease than neutralizing antibodies, for instance by interaction of the antibody constant domain with Fc receptors. This interaction is determined by two characteristics, antibody subclass (irreversible) and antibody glycosylation (fast and reversible) that can for example impact the affinity for Fc receptors.<xref rid="imm13012-bib-0067" ref-type="ref">67</xref> The glycosylation profile of antigen&#x02010;specific antibodies is changed upon vaccination, whereas the glycosylation profile of total IgG is not affected. Interestingly, despite very different pre&#x02010;vaccination glycosylation levels in populations in different parts of the world,<xref rid="imm13012-bib-0068" ref-type="ref">68</xref> profiles induced by vaccination are similar, as was shown after influenza vaccination.<xref rid="imm13012-bib-0069" ref-type="ref">69</xref>
</p><p>However, different vaccine formulations can induce different glycosylation profiles.<xref rid="imm13012-bib-0068" ref-type="ref">68</xref> This is likely also influenced by the adjuvant present in the formulation, either directly or via cytokine induction.<xref rid="imm13012-bib-0070" ref-type="ref">70</xref> Though the biological implications of these differences are not yet clear, the recent developments in systems serology demonstrate that multiple parameters of the antibody response, such as IgG subtype and antibody glycosylation among others, influence antibody functionally and therefore vaccine efficacy.<xref rid="imm13012-bib-0071" ref-type="ref">71</xref>, <xref rid="imm13012-bib-0072" ref-type="ref">72</xref>, <xref rid="imm13012-bib-0073" ref-type="ref">73</xref>
</p></sec><sec id="imm13012-sec-0007"><title>Data analysis and bioinformatics</title><p>One of the difficulties in systems approaches is the amount of data. Statistical evaluation, visualization and extracting meaningful conclusions are major challenges and require multiple tools and expertises.<xref rid="imm13012-bib-0074" ref-type="ref">74</xref>, <xref rid="imm13012-bib-0075" ref-type="ref">75</xref> New technologies in systems vaccinology such as metabolomics may require different statistical and bioinformatic analysis strategies compared with transcriptomics and proteomics data sets, as described by Ren <italic>et al</italic>.<xref rid="imm13012-bib-0076" ref-type="ref">76</xref> Visualization of data from full genomes or proteomes was initially performed with tools applying e.g. heatmaps, Venn diagrams and network analysis, e.g. with Cytoscape.<xref rid="imm13012-bib-0077" ref-type="ref">77</xref> These allowed visualization of numerous individual data points or groups, but also the clustering of related data points. Additionally, the generation of multiple systems&#x02010;scale data sets enables the comparison of immune responses induced by different vaccines in an unbiased manner.<xref rid="imm13012-bib-0078" ref-type="ref">78</xref>, <xref rid="imm13012-bib-0079" ref-type="ref">79</xref> Hierarchical Stochastic Neighborhood Embedding (HSNE) enables us to visualize data of cellular composition of millions of cells in detail up to the single&#x02010;cell level.<xref rid="imm13012-bib-0080" ref-type="ref">80</xref> Although these graphs provide an easier perspective on trends in the data sets, they are not designed to provide information on the biological function of individual data points. The development of data mining tools (Fig. <xref rid="imm13012-fig-0001" ref-type="fig">1</xref>) has given scientists a handle to translate their data sets into the description of relevant biological processes.<xref rid="imm13012-bib-0081" ref-type="ref">81</xref> This allows for investigation of the involvement and mutual interaction of pathways, processes and cell types. Tools that are focused on pathway analysis include DAVID,<xref rid="imm13012-bib-0082" ref-type="ref">82</xref> Pathway&#x02010;Express,<xref rid="imm13012-bib-0083" ref-type="ref">83</xref> Gene Onthology (GO)<xref rid="imm13012-bib-0084" ref-type="ref">84</xref> and the Kyoto Encyclopedia of Genes and Genomes (KEGG).<xref rid="imm13012-bib-0085" ref-type="ref">85</xref> With BioGPS, the involvement of cells or the different stages in cell activation can be investigated.<xref rid="imm13012-bib-0086" ref-type="ref">86</xref> This has also led to the development of specialized databases for specific research topics. For example, InnateDB contains data on innate immune responses<xref rid="imm13012-bib-0087" ref-type="ref">87</xref> while INTERFEROME focuses on interferon&#x02010;related processes<xref rid="imm13012-bib-0088" ref-type="ref">88</xref> and the CEMiTool can be used for co&#x02010;expression analyses and discovery of functionality of genes.<xref rid="imm13012-bib-0089" ref-type="ref">89</xref> For the discovery and analysis of the repertoire of T&#x02010; and B&#x02010;cell receptor sequences, VDJviz can be applied for the routine analysis and quality control of sequencing of immune repertoires<xref rid="imm13012-bib-0090" ref-type="ref">90</xref> and VDJdb is designed for the annotation of T&#x02010;cell receptor repertoire data.<xref rid="imm13012-bib-0091" ref-type="ref">91</xref> These databases evolve and expand continuously based on novel data, scientific insights and technologies. Depending on the choice of data mining tools, the outcome of results might differ. However, within the Human Vaccines Project,<xref rid="imm13012-bib-0092" ref-type="ref">92</xref> researchers demonstrated that there was no difference in the outcome of their data when it was either analyzed using a tool based on prior knowledge, in this case the NetAnalyst platform, or with an unbiased tool, DIABLO.</p><p>In addition, to generate knowledge and understanding, large data sets are used in computational systems biology studies to predict host immune responses.<xref rid="imm13012-bib-0075" ref-type="ref">75</xref>, <xref rid="imm13012-bib-0093" ref-type="ref">93</xref> From the antigen point of view, machine&#x02010;learning tools are widely applied to predict B&#x02010;cell<xref rid="imm13012-bib-0094" ref-type="ref">94</xref> and T&#x02010;cell epitopes<xref rid="imm13012-bib-0095" ref-type="ref">95</xref> and novel tools such as the IL17eScan<xref rid="imm13012-bib-0096" ref-type="ref">96</xref> enable us to predict the capacity of epitopes to induce interleukin&#x02010;17. All these data can be gathered <italic>in silico</italic> prior to or simultaneous with laboratory studies to confirm the role of host biomarkers and antigen epitopes in vaccine responses.</p></sec></sec><sec id="imm13012-sec-0008"><title>Application of systems vaccinology in vaccine research</title><p>In each phase of vaccine development (Fig. <xref rid="imm13012-fig-0002" ref-type="fig">2</xref>), systems vaccinology techniques can be applied to improve the quality of the vaccine development process as well as decreasing the risk of late&#x02010;stage failure as a result of increased knowledge (Table <xref rid="imm13012-tbl-0002" ref-type="table">2</xref>). Apart from host&#x02013;vaccine responses, a systems approach can also provide essential information on the vaccine itself, more specifically the antigen composition. Most vaccines belong to one of four groups: (i) live&#x02010;attenuated, (ii) whole inactivated, (iii) subunit and (iv) conjugate vaccines. Detailed vaccine characterization is mainly of interest for complex multi&#x02010;protein vaccines such as live&#x02010;attenuated and inactivated (bacterial) vaccines if for instance batch consistency must be proven.</p><fig fig-type="Figure" xml:lang="en" id="imm13012-fig-0002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Vaccine development and application of systems vaccinology. Systems vaccinology can be applied to all phases implementing different techniques (e.g. transcriptomics, proteomics, cell&#x02010;based assays) to provide detailed insight in different research objectives, such as composition, immunogenicity and safety of the vaccine. The host&#x02013;pathogen responses are not essential for vaccine development but since protection after infection is often superior in terms of efficacy &#x02013; but not safety &#x02013; this knowledge can be useful throughout the vaccine development chain, as illustrated by arrows.</p></caption><graphic id="nlm-graphic-5" xlink:href="IMM-156-33-g002"/></fig><table-wrap id="imm13012-tbl-0002" xml:lang="en" orientation="portrait" position="float"><label>Table 2</label><caption><p>Applications of systems vaccinology</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Aim, deliverables</th><th align="left" valign="top" rowspan="1" colspan="1">Benefits</th><th align="left" valign="top" rowspan="1" colspan="1">Examples</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Predicting responses</td><td align="left" rowspan="1" colspan="1">Clinical development, post&#x02010;marketing surveillance</td><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0002" ref-type="ref">2</xref>, <xref rid="imm13012-bib-0003" ref-type="ref">3</xref>, <xref rid="imm13012-bib-0014" ref-type="ref">14</xref>, <xref rid="imm13012-bib-0120" ref-type="ref">120</xref>, <xref rid="imm13012-bib-0121" ref-type="ref">121</xref>, <xref rid="imm13012-bib-0122" ref-type="ref">122</xref>, <xref rid="imm13012-bib-0123" ref-type="ref">123</xref>, <xref rid="imm13012-bib-0124" ref-type="ref">124</xref>, <xref rid="imm13012-bib-0125" ref-type="ref">125</xref>, <xref rid="imm13012-bib-0126" ref-type="ref">126</xref>, <xref rid="imm13012-bib-0129" ref-type="ref">129</xref>, <xref rid="imm13012-bib-0175" ref-type="ref">175</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Understand mode of action of vaccines</td><td align="left" rowspan="1" colspan="1">Risk mitigation: less late&#x02010;stage failure</td><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0127" ref-type="ref">127</xref>, <xref rid="imm13012-bib-0129" ref-type="ref">129</xref>, <xref rid="imm13012-bib-0176" ref-type="ref">176</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Identify universal vaccine signatures</td><td align="left" rowspan="1" colspan="1">Improve vaccine development</td><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0079" ref-type="ref">79</xref>, <xref rid="imm13012-bib-0118" ref-type="ref">118</xref>, <xref rid="imm13012-bib-0133" ref-type="ref">133</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Select new immune modulators and delivery systems</td><td align="left" rowspan="1" colspan="1">
Risk mitigation: less early&#x02010;stage failure<break/>
Better vaccines
</td><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0013" ref-type="ref">13</xref>, <xref rid="imm13012-bib-0111" ref-type="ref">111</xref>, <xref rid="imm13012-bib-0113" ref-type="ref">113</xref>, <xref rid="imm13012-bib-0128" ref-type="ref">128</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Assess vaccine safety and adverse effects</td><td align="left" rowspan="1" colspan="1">Clinical development, post&#x02010;marketing surveillance</td><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0117" ref-type="ref">117</xref>, <xref rid="imm13012-bib-0118" ref-type="ref">118</xref>, <xref rid="imm13012-bib-0119" ref-type="ref">119</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Understand mode of action of infection</td><td align="left" rowspan="1" colspan="1">Host&#x02013;pathogen interaction</td><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0100" ref-type="ref">100</xref>, <xref rid="imm13012-bib-0102" ref-type="ref">102</xref>, <xref rid="imm13012-bib-0104" ref-type="ref">104</xref>, <xref rid="imm13012-bib-0105" ref-type="ref">105</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Rational vaccine design</td><td align="left" rowspan="1" colspan="1">
Risk mitigation: less early&#x02010;stage failure<break/>
Facilitates regulatory acceptance
</td><td align="left" rowspan="1" colspan="1">N.A.</td></tr><tr><td align="left" rowspan="1" colspan="1">Development of animal models</td><td align="left" rowspan="1" colspan="1">
Improved early development<break/>
Risk mitigation: facilitates preclinical to clinical decision.
</td><td align="left" rowspan="1" colspan="1">
<xref rid="imm13012-bib-0118" ref-type="ref">118</xref>
</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><sec id="imm13012-sec-0009"><title>Exploratory studies in vaccine development</title><p>During the discovery phase a systems approach can be implemented to investigate vaccine composition as is especially interesting for complex multi&#x02010;protein vaccines (Fig. <xref rid="imm13012-fig-0002" ref-type="fig">2</xref>). For example, transcriptomics and/or proteomics approaches can be applied during strain generation for an inactivated vaccine to provide detailed information on protein composition and, more specifically, the proportion of immunogenic proteins. These techniques can subsequently be used for process development to verify whether or not the product is similar when produced at a larger scale. This was, for instance, demonstrated for pertussis whole&#x02010;cell vaccines.<xref rid="imm13012-bib-0097" ref-type="ref">97</xref> Information on the relationship between cultivation conditions and the composition of the final vaccine, considerably enhances the process of optimizing vaccine efficacy. In addition, it reveals key process parameters that can subsequently be tightly monitored, making the process more consistent and thereby eventual vaccine release easier.</p><p>To study the vaccine responses in the discovery phase, systems vaccinology methods can be used to study the mechanism of action of vaccines or adjuvants, both <italic>in vitro</italic> as well as in experimental animals (Fig. <xref rid="imm13012-fig-0002" ref-type="fig">2</xref>). <italic>In vitro</italic> cell&#x02010;based assays allow the gain of information on the magnitude and direction of the innate response, but they lack the possibility to study coherent interactions between innate and adaptive immune responses. Especially in the transition from innate to adaptive responses, a lot of immunological information is still missing.</p><p>While the main focus in systems vaccinology is on vaccine&#x02010;induced responses, pathogen&#x02010;induced responses during infection are also of great interest, as these can enable the discovery of potential markers of, or mechanisms involved in, protective immunity, or unwanted immunological effects such as immune evasion (Fig. <xref rid="imm13012-fig-0002" ref-type="fig">2</xref>). Systems biology can assist to investigate host&#x02013;pathogen interactions by looking at pathogen behavior and clearance after infection. A natural infection sometimes induces effective protection, e.g. mumps, that may serve as a benchmark for a vaccine, whereas other pathogens may display immune evasive or suppressive responses, which one would like to avoid in a vaccine&#x02010;induced response. A systems&#x02010;based approach was for instance used to investigate infection&#x02010;induced responses during sepsis.<xref rid="imm13012-bib-0098" ref-type="ref">98</xref> In terms of vaccine&#x02010;preventable diseases, investigators have looked at infection&#x02010;induced responses for pathogens such as RSV,<xref rid="imm13012-bib-0099" ref-type="ref">99</xref>, <xref rid="imm13012-bib-0100" ref-type="ref">100</xref>, <xref rid="imm13012-bib-0101" ref-type="ref">101</xref>
<italic>M</italic>. <italic>tuberculosis</italic>,<xref rid="imm13012-bib-0102" ref-type="ref">102</xref>
<italic>B. pertussis</italic>
<xref rid="imm13012-bib-0012" ref-type="ref">12</xref>, <xref rid="imm13012-bib-0078" ref-type="ref">78</xref>, <xref rid="imm13012-bib-0103" ref-type="ref">103</xref> and influenza.<xref rid="imm13012-bib-0104" ref-type="ref">104</xref>, <xref rid="imm13012-bib-0105" ref-type="ref">105</xref> The course of a <italic>B. pertussis</italic> infection was investigated in mice to unravel molecular and cellular signatures of the effective infection&#x02010;induced immunity.<xref rid="imm13012-bib-0012" ref-type="ref">12</xref>, <xref rid="imm13012-bib-0106" ref-type="ref">106</xref> Results indicated that a <italic>B. pertussis</italic> infection induced T helper type 17 (Th17) cells and mucosal IgA responses that were preceded by a prolonged acute&#x02010;phase response, broad pathogen recognition and early gene signatures of subsequent T&#x02010;cell recruitment in the lungs.<xref rid="imm13012-bib-0012" ref-type="ref">12</xref> In addition, the infection led to enhanced activation of pulmonary innate immune cells and markers indicating recruitment of CCR6<sup>+</sup> B&#x02010;cells and Th17 cells.<xref rid="imm13012-bib-0106" ref-type="ref">106</xref> These promising markers of infection&#x02010;induced responses should ideally be confirmed in human <italic>B. pertussis</italic> challenge models.<xref rid="imm13012-bib-0107" ref-type="ref">107</xref> In a comparative network analysis of two data sets, the pulmonary molecular signatures that preceded the effector cells in <italic>B. pertussis</italic> infection&#x02010;induced&#x02010;immunity<xref rid="imm13012-bib-0012" ref-type="ref">12</xref> were compared with signatures induced upon pulmonary immunization with a novel Outer Membrane Vesicle Pertussis vaccine (omvPV).<xref rid="imm13012-bib-0015" ref-type="ref">15</xref> Network analysis demonstrated that similar genes and pathways were involved in both responses but that the intensity and kinetics between infection&#x02010;induced and vaccine&#x02010;induced responses were different. Both responses did, however, result in induction of mucosal immunity and better protection compared with subcutaneous vaccine administration.</p><p>Systems approaches have also been used to investigate innate responses, for example responses induced by adjuvants.<xref rid="imm13012-bib-0108" ref-type="ref">108</xref>
<italic>In vitro</italic> studies were performed to investigate monocyte&#x02010;specific responses induced by alum salts using a proteomics approach<xref rid="imm13012-bib-0109" ref-type="ref">109</xref> and to study subset&#x02010;specific dendritic cell responses following lipopolysaccharide stimulation using a transcriptomics approach.<xref rid="imm13012-bib-0110" ref-type="ref">110</xref> These extensive <italic>in vitro</italic> studies provide insight into novel markers, pathways and cell subsets activated by adjuvants. Yet the complexity of cell&#x02010;to&#x02010;cell interaction during immune responses requires <italic>in vivo</italic> studies. This was also addressed by Mosca <italic>et al</italic>.,<xref rid="imm13012-bib-0013" ref-type="ref">13</xref> who conducted one of the first systems&#x02010;based studies in mice for better understanding of adjuvants, such as MF59, alum, CpG ODN and <italic>&#x003b1;</italic>&#x02010;GalCer. Adjuvant&#x02010;induced responses were profiled in muscle at the site of injection. This provided comparative information on plain adjuvant responses such as the fact that CpG elicited stronger systemic innate responses compared with MF59 and alum. Others have studied the responses of adjuvants in combination with antigen, that might also influence the immune response. Olafsdottir <italic>et al</italic>.<xref rid="imm13012-bib-0111" ref-type="ref">111</xref> determined molecular signatures induced in mice of four clinically tested vaccine adjuvants (CAF01, IC31 GLA&#x02010;SE and Alum) using a tuberculosis vaccine candidate (H56) as model antigen. With a transcriptomics analysis, signatures of T follicular helper (T<sub>fh</sub>) and germinal center (GC) B&#x02010;cell responses were found to be enhanced in adjuvated vaccines compared with those of the H56 antigen alone. Using a similar combination of H56 adjuvanted with CAF01, Santoro <italic>et al</italic>.<xref rid="imm13012-bib-0112" ref-type="ref">112</xref> applied systems vaccinology to demonstrate that recall innate responses following boosting were modulated by the use of adjuvant in the primary immunization. Lindqvist <italic>et al</italic>.<xref rid="imm13012-bib-0113" ref-type="ref">113</xref> focused on specifying the molecular signatures in mice induced by mucosal adjuvants for vaccination against sexually transmitted infections.</p><p>Relevant animal models to study infection are not always available. In such cases, the application of systems approaches in vaccination studies can provide valuable information on the mechanism of action of candidate vaccines. G&#x000f3;mez <italic>et al</italic>. unraveled transcriptomic activation markers of human myeloid and plasmacytoid dendritic cells upon stimulation with a vaccine candidate against HIV/AIDS, based on an MVA&#x02010;based vector. Subsequently, HIV&#x02010;1&#x02010;specific CD4<sup>+</sup> and CD8<sup>+</sup> T&#x02010;cell memory responses were demonstrated <italic>in vivo</italic>.<xref rid="imm13012-bib-0114" ref-type="ref">114</xref> Strouts <italic>et al</italic>.<xref rid="imm13012-bib-0115" ref-type="ref">115</xref> were able to link early specific gene transcripts related to T&#x02010;cell activation and type I interferon response to the magnitude of neutralizing antibody titers after immunization with a live&#x02010;attenuated tetravalent dengue vaccine in non&#x02010;human primates. As part of the development of a novel Outer Membrane Vesicle Pertussis vaccine (omvPV), vaccine&#x02010;induced responses were investigated in mice. An extensive proteomics approach for antibody profiling was used to determine the distinct antibody specificity and subclass distribution induced by different pertussis vaccines.<xref rid="imm13012-bib-0059" ref-type="ref">59</xref> Transcriptome and cytokine profiling demonstrated reduced pro&#x02010;inflammatory responses, potentially leading to less adverse effects by the omvPV compared with a classic whole&#x02010;cell pertussis vaccine while maintaining the vaccine efficacy.<xref rid="imm13012-bib-0116" ref-type="ref">116</xref> To investigate the effect of the route of immunization on protective immunity, the responses induced by subcutaneous and pulmonary administration of omvPV in mice were compared.<xref rid="imm13012-bib-0015" ref-type="ref">15</xref> The study demonstrated improved mucosal immunity, and therefore protection, against <italic>B. pertussis</italic> after pulmonary immunization. Finally, in terms of vaccine safety, Mizukami <italic>et al</italic>.<xref rid="imm13012-bib-0117" ref-type="ref">117</xref> applied the systems&#x02010;approach in a rat model to predict safety and batch&#x02010;to&#x02010;batch consistency of influenza vaccines. Wang <italic>et al</italic>.<xref rid="imm13012-bib-0118" ref-type="ref">118</xref> investigated blood gene signatures in non&#x02010;human primates immunized with seven marketed or experimental vaccines to isolate markers of vaccine efficacy and safety. Whereas overlapping trends in markers of efficacy were found between some vaccines, no markers were found correlating to adverse effects.</p></sec><sec id="imm13012-sec-0010"><title>Clinical studies</title><p>Predictive markers that have been found in the exploratory studies (described in the previous section) can be applied in subsequent clinical studies. Moreover, systems vaccinology analyses are also useful in a clinical study itself to obtain better insight into safety and efficacy (Fig. <xref rid="imm13012-fig-0002" ref-type="fig">2</xref>). However, to our knowledge in only a few clinical studies has systems vaccinology been performed to assess signatures that correlate to adverse effects, such as fever and seizures. In the public&#x02013;private project BIOVACSAFE, systems approaches are applied to investigate markers correlating to vaccine safety in human and animal models potentially providing novel markers.<xref rid="imm13012-bib-0119" ref-type="ref">119</xref> Investigators have conducted systems&#x02010;based studies in humans investigating vaccine candidates against Ebola (rVSV&#x02010;ZEBOV),<sup>120</sup> HIV&#x02010;1,<xref rid="imm13012-bib-0121" ref-type="ref">121</xref> malaria (RTS,S)<xref rid="imm13012-bib-0122" ref-type="ref">122</xref>, <xref rid="imm13012-bib-0123" ref-type="ref">123</xref> and <italic>M</italic>. <italic>tuberculosis</italic> (M72/AS01).<xref rid="imm13012-bib-0124" ref-type="ref">124</xref> For Ebola (rVSV&#x02010;ZEBOV), IP&#x02010;10 and CXCR6<sup>+</sup> natural killer (NK) cells were independently correlating with antibody titers, suggesting that IP&#x02010;10 could be a potential target to influence vaccine&#x02010;induced responses.<xref rid="imm13012-bib-0120" ref-type="ref">120</xref> Anderson <italic>et al</italic>.<xref rid="imm13012-bib-0121" ref-type="ref">121</xref> investigated transcriptome profiles in the blood of healthy volunteers following immunization with a novel HIV&#x02010;1 vaccine adjuvanted with a Toll&#x02010;like receptor 4 agonist. High responders, based on serum antibodies, contained modules of genes expressed in NK cells, whereas modules of genes related to myeloid cells, monocytes and integrin cell surface interactions were detected in low responders. These signatures enable vaccine responses to be distinguished in an early phase and perhaps even allows steering of immune responses in low responders by adjustment of the vaccine. In a phase I randomized controlled trial using AS03&#x02010;adjuvanted and unadjuvanted inactivated split&#x02010;virus H5N1 influenza vaccines, the effect of adjuvant on vaccine&#x02010;induced responses, such as serum cytokines, antibody titers, and gene expression levels, was investigated. This led to novel insights into antigen processing, presentation markers in neutrophils and revealed the correlation of serum IP&#x02010;10 levels with proliferation of NK cells.<xref rid="imm13012-bib-0125" ref-type="ref">125</xref> Interestingly, for the prediction of protection induced by malaria (RTS,S) immunization, NK cells correlated negatively whereas positive correlations were detected for molecular signatures of B&#x02010;cells and plasma cells<xref rid="imm13012-bib-0122" ref-type="ref">122</xref> and the nuclear factor&#x02010;<italic>&#x003ba;</italic>B and interferon&#x02010;<italic>&#x003b3;</italic> pathways.<xref rid="imm13012-bib-0123" ref-type="ref">123</xref> These findings indicate that different vaccine&#x02013;adjuvant combinations may induce different immune (non)effective responses.</p></sec><sec id="imm13012-sec-0011"><title>Post&#x02010;marketing studies</title><p>After vaccines have been licensed and introduced on the market, post&#x02010;marketing surveillance studies are performed to monitor vaccine safety and efficacy in larger populations (Fig. <xref rid="imm13012-fig-0002" ref-type="fig">2</xref>). At this point in the vaccine life cycle, correlates of protection, or surrogates thereof, are sometimes known, however the mechanism of action is often underexposed. Systems approaches in this phase are not routinely applied, as far as we know. The validation of the methods is complex and expensive, with the added value not yet proven convincingly. However, pioneering studies have demonstrated that vaccine efficacy after yellow fever and influenza vaccination could be predicted in an early stage after immunization by analyzing molecular signatures.<xref rid="imm13012-bib-0014" ref-type="ref">14</xref>, <xref rid="imm13012-bib-0126" ref-type="ref">126</xref>, <xref rid="imm13012-bib-0127" ref-type="ref">127</xref> For the yellow fever vaccine, the enhanced levels of specific gene expression profiles in blood obtained 1 to 7 days after vaccination were predictive for antigen&#x02010;specific CD8<sup>+</sup> T&#x02010;cell levels and antibody titers usually obtained 60 days after immunization, thus inducing a significant time advantage. In a clinical phase, regulators might want to see positive classical end&#x02010;points but for post&#x02010;marketing purposes this approach of looking at early correlates may be valuable. Furthermore, these studies are of value in comparative studies of different vaccine formulations. Nakaya <italic>et al</italic>.<xref rid="imm13012-bib-0128" ref-type="ref">128</xref> compared two different vaccine formulations, trivalent inactivated influenza vaccine (TIV) and MF59&#x02010;adjuvanted TIV (ATIV), in children and predicted influenza antibody titers 1 month after vaccination with a seasonal influenza vaccine across five consecutive seasons by analyzing specific signatures of innate immunity and plasma blasts.<xref rid="imm13012-bib-0129" ref-type="ref">129</xref> In addition, a systems biology approach could also be applied to investigate the differences in vaccine responsiveness in different target groups. For example, researchers predicted age&#x02010;related vaccine hypo&#x02010;responses against a hepatitis B vaccine in the elderly with a gene marker<xref rid="imm13012-bib-0130" ref-type="ref">130</xref> and exposed transcriptomic signatures of vaccine&#x02010;induced immunity, both cellular and humoral immune responses, after seasonal influenza vaccination specifically in older adults.<xref rid="imm13012-bib-0131" ref-type="ref">131</xref> Obviously, these post&#x02010;marketing surveillance studies facilitate further clinical development of improved vaccines or provide insight into general mechanisms that will enhance future vaccine development, even if correlates of protection are unknown.<xref rid="imm13012-bib-0132" ref-type="ref">132</xref>
</p><p>Finally, a great benefit of systems vaccinology studies is the ability to combine data sets from vaccine responses against different pathogens in integrative network modeling to reveal detailed insight into universal signatures of vaccine responsiveness.<xref rid="imm13012-bib-0078" ref-type="ref">78</xref>, <xref rid="imm13012-bib-0079" ref-type="ref">79</xref>, <xref rid="imm13012-bib-0118" ref-type="ref">118</xref>, <xref rid="imm13012-bib-0133" ref-type="ref">133</xref> Li <italic>et al</italic>.<xref rid="imm13012-bib-0079" ref-type="ref">79</xref> compared molecular signatures, induced by five different human vaccines against specific bacterial or viral infections, which could predict antibody responses. This indicates that investigating responses against a single pathogen can lead to universal markers that serve as benchmark for vaccine development against new emerging diseases. This also supports the desire for data obtained in systems&#x02010;approaches to be publicly available (open access) for future large meta&#x02010;analyses.</p></sec></sec><sec id="imm13012-sec-0012"><title>Future outlook</title><p>Systems vaccinology has been implemented in the different phases of the vaccine development chain and has become a relevant approach in the field of vaccinology. The recent progression in systems vaccinology has led to successful initiatives such as the ADITEC project<xref rid="imm13012-bib-0134" ref-type="ref">134</xref> that provided a novel gene expression method to analyze biomarkers of tuberculosis pathogenesis<xref rid="imm13012-bib-0135" ref-type="ref">135</xref> as well as a study where safety and immunogenicity of a novel vaccine against tuberculosis (VPM1002) were evaluated.<xref rid="imm13012-bib-0136" ref-type="ref">136</xref> To achieve maximum vaccine efficacy and safety, future vaccine research will have to focus on target groups such as neonates<xref rid="imm13012-bib-0137" ref-type="ref">137</xref>, <xref rid="imm13012-bib-0138" ref-type="ref">138</xref> or even on the development of personalized vaccines.<xref rid="imm13012-bib-0139" ref-type="ref">139</xref> Systems vaccinology approaches can be further applied to investigate the inter&#x02010;group differences in vaccine responsiveness between healthy adults and specific target groups such as infants, and elderly or immune&#x02010;deficient individuals.<xref rid="imm13012-bib-0140" ref-type="ref">140</xref>
</p><p>Investigating vaccine&#x02010;induced responses with systems vaccinology has led to a trend of gathering massive amounts of data going as deep as investigating every molecule in single cells. Acquiring large data sets is far easier than extracting novel relevant information from those data. Furthermore, the amount of data is constantly increasing, especially when combining data sets of different origin (genes versus proteins versus cells). This requires equally advanced tools for (i) data visualization and (ii) translation of content to knowledge and understanding, forcing a dialogue between vaccine developers and bioinformatics experts. In the future, implementation of artificial intelligence could assist in data processing and for data visualization online publications may become interactive allowing readers to scroll through, for example, the immune responses induced by immunization over time.</p><p>In summary, systems vaccinology is becoming a valuable tool in each phase of the vaccine development chain. The link with predicting immune responses beforehand is, however, still difficult. Small but important steps are currently taken towards application of the insights created by systems vaccinology. Recent studies show that the application of systems vaccinology is especially interesting for investigating complex or dangerous pathogens such as Ebola virus, HIV, malaria&#x02010;causing <italic>Plasmodium</italic> spp. and <italic>M</italic>. <italic>tuberculosis</italic> where phase 3 studies are challenging or even impossible,<xref rid="imm13012-bib-0120" ref-type="ref">120</xref>, <xref rid="imm13012-bib-0121" ref-type="ref">121</xref>, <xref rid="imm13012-bib-0122" ref-type="ref">122</xref>, <xref rid="imm13012-bib-0123" ref-type="ref">123</xref>, <xref rid="imm13012-bib-0124" ref-type="ref">124</xref> or even for investigating the heterologous or non&#x02010;specific effects that vaccines induce against other diseases.<xref rid="imm13012-bib-0141" ref-type="ref">141</xref> These promising changes call for the inclusion of systems vaccinology as early as possible in the vaccine development chain to better understand why some vaccines work and others do not. This will enable efficiency of vaccine development proportionally in the design phase and will lead to improved vaccine evaluation in early phases, thereby reducing time and costs.</p></sec><sec id="imm13012-sec-0013"><title>Author contribution</title><p>R.R., E.R., H.M., B.M. and G.K. wrote the review.</p></sec><sec id="imm13012-sec-0014"><title>Disclosures</title><p>The authors declare no competing interest.</p></sec></body><back><ref-list content-type="cited-references" id="imm13012-bibl-0001"><title>References</title><ref id="imm13012-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="imm13012-cit-0001">
<string-name>
<surname>Wack</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rappuoli</surname>
<given-names>R</given-names>
</string-name>. <article-title>Vaccinology at the beginning of the 21st century</article-title>. <source xml:lang="en">Curr Opin Immunol</source>
<year>2005</year>; <volume>17</volume>:<fpage>411</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">15950445</pub-id></mixed-citation></ref><ref id="imm13012-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="imm13012-cit-0002">
<string-name>
<surname>Oberg</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Kennedy</surname>
<given-names>RB</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Ovsyannikova</surname>
<given-names>IG</given-names>
</string-name>, <string-name>
<surname>Poland</surname>
<given-names>GA</given-names>
</string-name>. <article-title>Systems biology approaches to new vaccine development</article-title>. <source xml:lang="en">Curr Opin Immunol</source>
<year>2011</year>; <volume>23</volume>:<fpage>436</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="pmid">21570272</pub-id></mixed-citation></ref><ref id="imm13012-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="imm13012-cit-0003">
<string-name>
<surname>Pulendran</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Nakaya</surname>
<given-names>HI</given-names>
</string-name>. <article-title>Systems vaccinology</article-title>. <source xml:lang="en">Immunity</source>
<year>2010</year>; <volume>33</volume>:<fpage>516</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="pmid">21029962</pub-id></mixed-citation></ref><ref id="imm13012-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="imm13012-cit-0004">
<string-name>
<surname>Aderem</surname>
<given-names>A</given-names>
</string-name>. <article-title>Systems biology: its practice and challenges</article-title>. <source xml:lang="en">Cell</source>
<year>2005</year>; <volume>121</volume>:<fpage>511</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="pmid">15907465</pub-id></mixed-citation></ref><ref id="imm13012-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="imm13012-cit-0005">
<string-name>
<surname>Rappuoli</surname>
<given-names>R</given-names>
</string-name>. <article-title>Reverse vaccinology</article-title>. <source xml:lang="en">Curr Opin Microbiol</source>
<year>2000</year>; <volume>3</volume>:<fpage>445</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="pmid">11050440</pub-id></mixed-citation></ref><ref id="imm13012-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="imm13012-cit-0006">
<string-name>
<surname>Flanagan</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>Noho&#x02010;Konteh</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Ghazal</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Dickinson</surname>
<given-names>P</given-names>
</string-name>. <article-title>Transcriptional profiling technology for studying vaccine responses: an untapped goldmine</article-title>. <source xml:lang="en">Methods</source>
<year>2013</year>; <volume>60</volume>:<fpage>269</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="pmid">23578546</pub-id></mixed-citation></ref><ref id="imm13012-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="imm13012-cit-0007">
<string-name>
<surname>Touzot</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Dahirel</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Cappuccio</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Segura</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Hupe</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Soumelis</surname>
<given-names>V</given-names>
</string-name>. <article-title>Using transcriptional signatures to assess immune cell function: from basic mechanisms to immune&#x02010;related disease</article-title>. <source xml:lang="en">J Mol Biol</source>
<year>2015</year>; <volume>427</volume>:<fpage>3356</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="pmid">25986308</pub-id></mixed-citation></ref><ref id="imm13012-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="imm13012-cit-0008">
<string-name>
<surname>Brummelman</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Raeven</surname>
<given-names>RHM</given-names>
</string-name>, <string-name>
<surname>Helm</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Pennings</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Metz</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>van Eden</surname>
<given-names>W</given-names>
</string-name>
<italic>et al</italic>
<article-title>Transcriptome signature for dampened Th2 dominance in acellular pertussis vaccine&#x02010;induced CD4(+) T cell responses through TLR4 ligation</article-title>. <source xml:lang="en">Sci Rep</source>
<year>2016</year>; <volume>6</volume>:<fpage>25064</fpage>.<pub-id pub-id-type="pmid">27118638</pub-id></mixed-citation></ref><ref id="imm13012-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="imm13012-cit-0009">
<string-name>
<surname>Goldstein</surname>
<given-names>LD</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>YJ</given-names>
</string-name>, <string-name>
<surname>Dunne</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Mir</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hubschle</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Guillory</surname>
<given-names>J</given-names>
</string-name>
<italic>et al</italic>
<article-title>Massively parallel nanowell&#x02010;based single&#x02010;cell gene expression profiling</article-title>. <source xml:lang="en">BMC Genom</source>
<year>2017</year>; <volume>18</volume>:<fpage>519</fpage>.</mixed-citation></ref><ref id="imm13012-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="imm13012-cit-0010">
<string-name>
<surname>Stubbington</surname>
<given-names>MJT</given-names>
</string-name>, <string-name>
<surname>Rozenblatt&#x02010;Rosen</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Regev</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Teichmann</surname>
<given-names>SA</given-names>
</string-name>. <article-title>Single&#x02010;cell transcriptomics to explore the immune system in health and disease</article-title>. <source xml:lang="en">Science</source>
<year>2017</year>; <volume>358</volume>:<fpage>58</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="pmid">28983043</pub-id></mixed-citation></ref><ref id="imm13012-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="imm13012-cit-0011">
<string-name>
<surname>Lovatt</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Ruble</surname>
<given-names>BK</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Dueck</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>TK</given-names>
</string-name>, <string-name>
<surname>Fisher</surname>
<given-names>S</given-names>
</string-name>
<italic>et al</italic>
<article-title>Transcriptome <italic>in vivo</italic> analysis (TIVA) of spatially defined single cells in live tissue</article-title>. <source xml:lang="en">Nat Methods</source>
<year>2014</year>; <volume>11</volume>:<fpage>190</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">24412976</pub-id></mixed-citation></ref><ref id="imm13012-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="imm13012-cit-0012">
<string-name>
<surname>Raeven</surname>
<given-names>RHM</given-names>
</string-name>, <string-name>
<surname>Brummelman</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Pennings</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Nijst</surname>
<given-names>OE</given-names>
</string-name>, <string-name>
<surname>Kuipers</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Blok</surname>
<given-names>LE</given-names>
</string-name>
<italic>et al</italic>
<article-title>Molecular signatures of the evolving immune response in mice following a bordetella pertussis infection</article-title>. <source xml:lang="en">PLoS ONE</source>
<year>2014</year>; <volume>9</volume>:<fpage>e104548</fpage>.<pub-id pub-id-type="pmid">25137043</pub-id></mixed-citation></ref><ref id="imm13012-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="imm13012-cit-0013">
<string-name>
<surname>Mosca</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Tritto</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Muzzi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Monaci</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Bagnoli</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Iavarone</surname>
<given-names>C</given-names>
</string-name>
<italic>et al</italic>
<article-title>Molecular and cellular signatures of human vaccine adjuvants</article-title>. <source xml:lang="en">Proc Natl Acad Sci U S A</source>
<year>2008</year>; <volume>105</volume>:<fpage>10501</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">18650390</pub-id></mixed-citation></ref><ref id="imm13012-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="imm13012-cit-0014">
<string-name>
<surname>Nakaya</surname>
<given-names>HI</given-names>
</string-name>, <string-name>
<surname>Wrammert</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>EK</given-names>
</string-name>, <string-name>
<surname>Racioppi</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Marie&#x02010;Kunze</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Haining</surname>
<given-names>WN</given-names>
</string-name>
<italic>et al</italic>
<article-title>Systems biology of vaccination for seasonal influenza in humans</article-title>. <source xml:lang="en">Nat Immunol</source>
<year>2011</year>; <volume>12</volume>:<fpage>786</fpage>&#x02013;<lpage>95</lpage>.<pub-id pub-id-type="pmid">21743478</pub-id></mixed-citation></ref><ref id="imm13012-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="imm13012-cit-0015">
<string-name>
<surname>Raeven</surname>
<given-names>RHM</given-names>
</string-name>, <string-name>
<surname>Brummelman</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Pennings</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>van der Maas</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Helm</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Tilstra</surname>
<given-names>W</given-names>
</string-name>
<italic>et al</italic>
<article-title>Molecular and cellular signatures underlying superior immunity against Bordetella pertussis upon pulmonary vaccination</article-title>. <source xml:lang="en">Mucosal Immunol</source>
<year>2018</year>; <volume>11</volume>:<fpage>979</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="pmid">28930286</pub-id></mixed-citation></ref><ref id="imm13012-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="imm13012-cit-0016">
<string-name>
<surname>Ghazalpour</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bennett</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Petyuk</surname>
<given-names>VA</given-names>
</string-name>, <string-name>
<surname>Orozco</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Hagopian</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Mungrue</surname>
<given-names>IN</given-names>
</string-name>
<italic>et al</italic>
<article-title>Comparative analysis of proteome and transcriptome variation in mouse</article-title>. <source xml:lang="en">PLoS Genet</source>
<year>2011</year>; <volume>7</volume>:<fpage>e1001393</fpage>.<pub-id pub-id-type="pmid">21695224</pub-id></mixed-citation></ref><ref id="imm13012-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="imm13012-cit-0017">
<string-name>
<surname>Stoeckius</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hafemeister</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Stephenson</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Houck&#x02010;Loomis</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Chattopadhyay</surname>
<given-names>PK</given-names>
</string-name>, <string-name>
<surname>Swerdlow</surname>
<given-names>H</given-names>
</string-name>
<italic>et al</italic>
<article-title>Simultaneous epitope and transcriptome measurement in single cells</article-title>. <source xml:lang="en">Nat Methods</source>
<year>2017</year>; <volume>14</volume>:<fpage>865</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">28759029</pub-id></mixed-citation></ref><ref id="imm13012-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="imm13012-cit-0018">
<string-name>
<surname>Filipowicz</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Bhattacharyya</surname>
<given-names>SN</given-names>
</string-name>, <string-name>
<surname>Sonenberg</surname>
<given-names>N</given-names>
</string-name>. <article-title>Mechanisms of post&#x02010;transcriptional regulation by microRNAs: are the answers in sight?</article-title>
<source xml:lang="en">Nat Rev Genet</source>
<year>2008</year>; <volume>9</volume>:<fpage>102</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="pmid">18197166</pub-id></mixed-citation></ref><ref id="imm13012-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="imm13012-cit-0019">
<string-name>
<surname>Purcell</surname>
<given-names>AW</given-names>
</string-name>, <string-name>
<surname>Gorman</surname>
<given-names>JJ</given-names>
</string-name>. <article-title>Immunoproteomics: Mass spectrometry&#x02010;based methods to study the targets of the immune response</article-title>. <source xml:lang="en">Mol Cell Proteomics</source>
<year>2004</year>; <volume>3</volume>:<fpage>193</fpage>&#x02013;<lpage>208</lpage>.<pub-id pub-id-type="pmid">14718575</pub-id></mixed-citation></ref><ref id="imm13012-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="imm13012-cit-0020">
<string-name>
<surname>Hunt</surname>
<given-names>DF</given-names>
</string-name>, <string-name>
<surname>Henderson</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Shabanowitz</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Sakaguchi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Michel</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Sevilir</surname>
<given-names>N</given-names>
</string-name>
<italic>et al</italic>
<article-title>Characterization of peptides bound to the class I MHC molecule HLA&#x02010;A2.1 by mass spectrometry</article-title>. <source xml:lang="en">Science</source>
<year>1992</year>; <volume>255</volume>:<fpage>1261</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="pmid">1546328</pub-id></mixed-citation></ref><ref id="imm13012-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="imm13012-cit-0021">
<string-name>
<surname>Schellens</surname>
<given-names>IM</given-names>
</string-name>, <string-name>
<surname>Meiring</surname>
<given-names>HD</given-names>
</string-name>, <string-name>
<surname>Hoof</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Spijkers</surname>
<given-names>SN</given-names>
</string-name>, <string-name>
<surname>Poelen</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>van Gaans&#x02010;van den Brink</surname>
<given-names>JA</given-names>
</string-name>
<italic>et al</italic>
<article-title>Measles virus epitope presentation by HLA: novel insights into epitope selection, dominance, and microvariation</article-title>. <source xml:lang="en">Front Immunol</source>
<year>2015</year>; <volume>6</volume>:<fpage>546</fpage>.<pub-id pub-id-type="pmid">26579122</pub-id></mixed-citation></ref><ref id="imm13012-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="imm13012-cit-0022">
<string-name>
<surname>Spencer</surname>
<given-names>CT</given-names>
</string-name>, <string-name>
<surname>Bezbradica</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Ramos</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Arico</surname>
<given-names>CD</given-names>
</string-name>, <string-name>
<surname>Conant</surname>
<given-names>SB</given-names>
</string-name>, <string-name>
<surname>Gilchuk</surname>
<given-names>P</given-names>
</string-name>
<italic>et al</italic>
<article-title>Viral infection causes a shift in the self peptide repertoire presented by human MHC class I molecules</article-title>. <source xml:lang="en">Proteomics Clin Appl</source>
<year>2015</year>; <volume>9</volume>:<fpage>1035</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="pmid">26768311</pub-id></mixed-citation></ref><ref id="imm13012-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="imm13012-cit-0023">
<string-name>
<surname>Marcilla</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Alvarez</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Ramos&#x02010;Fernandez</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lombardia</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Paradela</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Albar</surname>
<given-names>JP</given-names>
</string-name>. <article-title>Comparative analysis of the endogenous peptidomes displayed by HLA&#x02010;B*27 and Mamu&#x02010;B*08: two MHC class I alleles associated with elite control of HIV/SIV infection</article-title>. <source xml:lang="en">J Proteome Res</source>
<year>2016</year>; <volume>15</volume>:<fpage>1059</fpage>&#x02013;<lpage>69</lpage>.<pub-id pub-id-type="pmid">26811146</pub-id></mixed-citation></ref><ref id="imm13012-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="imm13012-cit-0024">
<string-name>
<surname>Draheim</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wlodarczyk</surname>
<given-names>MF</given-names>
</string-name>, <string-name>
<surname>Crozat</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Saliou</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Alayi</surname>
<given-names>TD</given-names>
</string-name>, <string-name>
<surname>Tomavo</surname>
<given-names>S</given-names>
</string-name>
<italic>et al</italic>
<article-title>Profiling MHC II immunopeptidome of blood&#x02010;stage malaria reveals that cDC1 control the functionality of parasite&#x02010;specific CD4 T cells</article-title>. <source xml:lang="en">EMBO Mol Med</source>
<year>2017</year>; <volume>9</volume>:<fpage>1605</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="pmid">28935714</pub-id></mixed-citation></ref><ref id="imm13012-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="imm13012-cit-0025">
<string-name>
<surname>Creech</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Ting</surname>
<given-names>YS</given-names>
</string-name>, <string-name>
<surname>Goulding</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Sauld</surname>
<given-names>JFK</given-names>
</string-name>, <string-name>
<surname>Barthelme</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Rooney</surname>
<given-names>MS</given-names>
</string-name>
<italic>et al</italic>
<article-title>The role of mass spectrometry and proteogenomics in the advancement of HLA epitope prediction</article-title>. <source xml:lang="en">Proteomics</source>
<year>2018</year>; <volume>18</volume>:<fpage>e1700259</fpage>.<pub-id pub-id-type="pmid">29314742</pub-id></mixed-citation></ref><ref id="imm13012-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="imm13012-cit-0026">
<string-name>
<surname>Ebstein</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Textoris&#x02010;Taube</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Keller</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Golnik</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Vigneron</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Van den Eynde</surname>
<given-names>BJ</given-names>
</string-name>
<italic>et al</italic>
<article-title>Proteasomes generate spliced epitopes by two different mechanisms and as efficiently as non&#x02010;spliced epitopes</article-title>. <source xml:lang="en">Sci Rep</source>
<year>2016</year>; <volume>6</volume>:<fpage>24032</fpage>.<pub-id pub-id-type="pmid">27049119</pub-id></mixed-citation></ref><ref id="imm13012-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="imm13012-cit-0027">
<string-name>
<surname>Lim</surname>
<given-names>WC</given-names>
</string-name>, <string-name>
<surname>Khan</surname>
<given-names>AM</given-names>
</string-name>. <article-title>Mapping HLA&#x02010;A2, &#x02010;A3 and &#x02010;B7 supertype&#x02010;restricted T&#x02010;cell epitopes in the ebolavirus proteome</article-title>. <source xml:lang="en">BMC Genom</source>
<year>2018</year>; <volume>19</volume>(<issue>Suppl 1</issue>):<fpage>42</fpage>.</mixed-citation></ref><ref id="imm13012-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="imm13012-cit-0028">
<string-name>
<surname>Berkers</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>de Jong</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Schuurman</surname>
<given-names>KG</given-names>
</string-name>, <string-name>
<surname>Linnemann</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Meiring</surname>
<given-names>HD</given-names>
</string-name>, <string-name>
<surname>Janssen</surname>
<given-names>L</given-names>
</string-name>
<italic>et al</italic>
<article-title>Definition of proteasomal peptide splicing rules for high&#x02010;efficiency spliced peptide presentation by MHC class I molecules</article-title>. <source xml:lang="en">J Immunol</source>
<year>2015</year>; <volume>195</volume>:<fpage>4085</fpage>&#x02013;<lpage>95</lpage>.<pub-id pub-id-type="pmid">26401003</pub-id></mixed-citation></ref><ref id="imm13012-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="imm13012-cit-0029">
<string-name>
<surname>Liepe</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Marino</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Sidney</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Jeko</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bunting</surname>
<given-names>DE</given-names>
</string-name>, <string-name>
<surname>Sette</surname>
<given-names>A</given-names>
</string-name>
<italic>et al</italic>
<article-title>A large fraction of HLA class I ligands are proteasome&#x02010;generated spliced peptides</article-title>. <source xml:lang="en">Science</source>
<year>2016</year>; <volume>354</volume>:<fpage>354</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">27846572</pub-id></mixed-citation></ref><ref id="imm13012-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="imm13012-cit-0030">
<string-name>
<surname>Galassie</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Link</surname>
<given-names>AJ</given-names>
</string-name>. <article-title>Proteomic contributions to our understanding of vaccine and immune responses</article-title>. <source xml:lang="en">Proteomics Clin Appl</source>
<year>2015</year>; <volume>9</volume>:<fpage>972</fpage>&#x02013;<lpage>89</lpage>.<pub-id pub-id-type="pmid">26172619</pub-id></mixed-citation></ref><ref id="imm13012-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="imm13012-cit-0031">
<string-name>
<surname>Donnarumma</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Faleri</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Costantino</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Rappuoli</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Norais</surname>
<given-names>N</given-names>
</string-name>. <article-title>The role of structural proteomics in vaccine development: recent advances and future prospects</article-title>. <source xml:lang="en">Expert Rev Proteomics</source>
<year>2016</year>; <volume>13</volume>:<fpage>55</fpage>&#x02013;<lpage>68</lpage>.<pub-id pub-id-type="pmid">26714563</pub-id></mixed-citation></ref><ref id="imm13012-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="imm13012-cit-0032">
<string-name>
<surname>Guy</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Irani</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Beeson</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Webb</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Sali</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Richards</surname>
<given-names>JS</given-names>
</string-name>
<italic>et al</italic>
<article-title>Proteome&#x02010;wide mapping of immune features onto <italic>Plasmodium</italic> protein three&#x02010;dimensional structures</article-title>. <source xml:lang="en">Sci Rep</source>
<year>2018</year>; <volume>8</volume>:<fpage>4355</fpage>.<pub-id pub-id-type="pmid">29531293</pub-id></mixed-citation></ref><ref id="imm13012-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="imm13012-cit-0033">
<string-name>
<surname>Opuni</surname>
<given-names>KFM</given-names>
</string-name>, <string-name>
<surname>Al&#x02010;Majdoub</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yefremova</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>El&#x02010;Kased</surname>
<given-names>RF</given-names>
</string-name>, <string-name>
<surname>Koy</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Glocker</surname>
<given-names>MO</given-names>
</string-name>. <article-title>Mass spectrometric epitope mapping</article-title>. <source xml:lang="en">Mass Spectrom Rev</source>
<year>2018</year>; <volume>37</volume>:<fpage>229</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="pmid">27403762</pub-id></mixed-citation></ref><ref id="imm13012-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="imm13012-cit-0034">
<string-name>
<surname>Kao</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Chiu</surname>
<given-names>CL</given-names>
</string-name>, <string-name>
<surname>Vellucci</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Patel</surname>
<given-names>VR</given-names>
</string-name>, <string-name>
<surname>Guan</surname>
<given-names>S</given-names>
</string-name>
<italic>et al</italic>
<article-title>Development of a novel cross&#x02010;linking strategy for fast and accurate identification of cross&#x02010;linked peptides of protein complexes</article-title>. <source xml:lang="en">Mol Cell Proteomics</source>
<year>2011</year>; <volume>10</volume>:<fpage>M110 002212</fpage>.</mixed-citation></ref><ref id="imm13012-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="imm13012-cit-0035">
<string-name>
<surname>Barysz</surname>
<given-names>HM</given-names>
</string-name>, <string-name>
<surname>Malmstroem</surname>
<given-names>J</given-names>
</string-name>. <article-title>Development of large&#x02010;scale cross&#x02010;linking mass spectrometry</article-title>. <source xml:lang="en">Mol Cell Proteomics</source>
<year>2017</year>; <volume>17</volume>:<fpage>1055</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="pmid">28389583</pub-id></mixed-citation></ref><ref id="imm13012-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="imm13012-cit-0036">
<string-name>
<surname>Sinz</surname>
<given-names>A</given-names>
</string-name>. <article-title>Divide and conquer: cleavable cross&#x02010;linkers to study protein conformation and protein&#x02013;protein interactions</article-title>. <source xml:lang="en">Anal Bioanal Chem</source>
<year>2017</year>; <volume>409</volume>:<fpage>33</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="pmid">27734140</pub-id></mixed-citation></ref><ref id="imm13012-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="imm13012-cit-0037">
<string-name>
<surname>Liu</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Rijkers</surname>
<given-names>DT</given-names>
</string-name>, <string-name>
<surname>Post</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Heck</surname>
<given-names>AJ</given-names>
</string-name>. <article-title>Proteome&#x02010;wide profiling of protein assemblies by cross&#x02010;linking mass spectrometry</article-title>. <source xml:lang="en">Nat Methods</source>
<year>2015</year>; <volume>12</volume>:<fpage>1179</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="pmid">26414014</pub-id></mixed-citation></ref><ref id="imm13012-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="imm13012-cit-0038">
<string-name>
<surname>Nessen</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Kramer</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Back</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Baskin</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Smeenk</surname>
<given-names>LE</given-names>
</string-name>, <string-name>
<surname>de Koning</surname>
<given-names>LJ</given-names>
</string-name>
<italic>et al</italic>
<article-title>Selective enrichment of azide&#x02010;containing peptides from complex mixtures</article-title>. <source xml:lang="en">J Proteome Res</source>
<year>2009</year>; <volume>8</volume>:<fpage>3702</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="pmid">19402736</pub-id></mixed-citation></ref><ref id="imm13012-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="imm13012-cit-0039">
<string-name>
<surname>Eichelbaum</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Winter</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Berriel Diaz</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Herzig</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Krijgsveld</surname>
<given-names>J</given-names>
</string-name>. <article-title>Selective enrichment of newly synthesized proteins for quantitative secretome analysis</article-title>. <source xml:lang="en">Nat Biotechnol</source>
<year>2012</year>; <volume>30</volume>:<fpage>984</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="pmid">23000932</pub-id></mixed-citation></ref><ref id="imm13012-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="imm13012-cit-0040">
<string-name>
<surname>Dieterich</surname>
<given-names>DC</given-names>
</string-name>, <string-name>
<surname>Link</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Graumann</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Tirrell</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Schuman</surname>
<given-names>EM</given-names>
</string-name>. <article-title>Selective identification of newly synthesized proteins in mammalian cells using bioorthogonal noncanonical amino acid tagging (BONCAT)</article-title>. <source xml:lang="en">Proc Natl Acad Sci U S A</source>
<year>2006</year>; <volume>103</volume>:<fpage>9482</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">16769897</pub-id></mixed-citation></ref><ref id="imm13012-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="imm13012-cit-0041">
<string-name>
<surname>Eichelbaum</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Krijgsveld</surname>
<given-names>J</given-names>
</string-name>. <article-title>Rapid temporal dynamics of transcription, protein synthesis, and secretion during macrophage activation</article-title>. <source xml:lang="en">Mol Cell Proteomics</source>
<year>2014</year>; <volume>13</volume>:<fpage>792</fpage>&#x02013;<lpage>810</lpage>.<pub-id pub-id-type="pmid">24396086</pub-id></mixed-citation></ref><ref id="imm13012-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="imm13012-cit-0042">
<string-name>
<surname>Frost</surname>
<given-names>DC</given-names>
</string-name>, <string-name>
<surname>Greer</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>L</given-names>
</string-name>. <article-title>High&#x02010;resolution enabled 12&#x02010;plex DiLeu isobaric tags for quantitative proteomics</article-title>. <source xml:lang="en">Anal Chem</source>
<year>2015</year>; <volume>87</volume>:<fpage>1646</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="pmid">25405479</pub-id></mixed-citation></ref><ref id="imm13012-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="imm13012-cit-0043">
<string-name>
<surname>Potts</surname>
<given-names>GK</given-names>
</string-name>, <string-name>
<surname>Voigt</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Bailey</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Rose</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Westphall</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Hebert</surname>
<given-names>AS</given-names>
</string-name>
<italic>et al</italic>
<article-title>Neucode labels for multiplexed, absolute protein quantification</article-title>. <source xml:lang="en">Anal Chem</source>
<year>2016</year>; <volume>88</volume>:<fpage>3295</fpage>&#x02013;<lpage>303</lpage>.<pub-id pub-id-type="pmid">26882330</pub-id></mixed-citation></ref><ref id="imm13012-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="imm13012-cit-0044">
<string-name>
<surname>Nyman</surname>
<given-names>TA</given-names>
</string-name>, <string-name>
<surname>Lorey</surname>
<given-names>MB</given-names>
</string-name>, <string-name>
<surname>Cypryk</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Matikainen</surname>
<given-names>S</given-names>
</string-name>. <article-title>Mass spectrometry&#x02010;based proteomic exploration of the human immune system: focus on the inflammasome, global protein secretion, and T cells</article-title>. <source xml:lang="en">Expert Rev Proteomics</source>
<year>2017</year>; <volume>14</volume>:<fpage>395</fpage>&#x02013;<lpage>407</lpage>.<pub-id pub-id-type="pmid">28406322</pub-id></mixed-citation></ref><ref id="imm13012-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="imm13012-cit-0045">
<string-name>
<surname>Hagan</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Pulendran</surname>
<given-names>B</given-names>
</string-name>. <article-title>Will systems biology deliver its promise and contribute to the development of new or improved vaccines? From data to understanding through systems biology</article-title>. <source xml:lang="en">Cold Spring Harb Perspect Biol</source>
<year>2018</year>; <volume>10</volume>:<fpage>pii: a028894</fpage>.</mixed-citation></ref><ref id="imm13012-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="imm13012-cit-0046">
<string-name>
<surname>Li</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sullivan</surname>
<given-names>NL</given-names>
</string-name>, <string-name>
<surname>Rouphael</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Banton</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Maddur</surname>
<given-names>MS</given-names>
</string-name>
<italic>et al</italic>
<article-title>Metabolic phenotypes of response to vaccination in humans</article-title>. <source xml:lang="en">Cell</source>
<year>2017</year>; <volume>169</volume>:<fpage>862</fpage>&#x02013;<lpage>77</lpage>. e817.<pub-id pub-id-type="pmid">28502771</pub-id></mixed-citation></ref><ref id="imm13012-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="imm13012-cit-0047">
<string-name>
<surname>Dunn</surname>
<given-names>WB</given-names>
</string-name>, <string-name>
<surname>Broadhurst</surname>
<given-names>DI</given-names>
</string-name>, <string-name>
<surname>Atherton</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Goodacre</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Griffin</surname>
<given-names>JL</given-names>
</string-name>. <article-title>Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy</article-title>. <source xml:lang="en">Chem Soc Rev</source>
<year>2011</year>; <volume>40</volume>:<fpage>387</fpage>&#x02013;<lpage>426</lpage>.<pub-id pub-id-type="pmid">20717559</pub-id></mixed-citation></ref><ref id="imm13012-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="imm13012-cit-0048">
<string-name>
<surname>Bousso</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Moreau</surname>
<given-names>HD</given-names>
</string-name>. <article-title>Functional immunoimaging: the revolution continues</article-title>. <source xml:lang="en">Nat Rev Immunol</source>
<year>2012</year>; <volume>12</volume>:<fpage>858</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="pmid">23175230</pub-id></mixed-citation></ref><ref id="imm13012-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="imm13012-cit-0049">
<string-name>
<surname>Chattopadhyay</surname>
<given-names>PK</given-names>
</string-name>, <string-name>
<surname>Gierahn</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Roederer</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Love</surname>
<given-names>JC</given-names>
</string-name>. <article-title>Single&#x02010;cell technologies for monitoring immune systems</article-title>. <source xml:lang="en">Nat Immunol</source>
<year>2014</year>; <volume>15</volume>:<fpage>128</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="pmid">24448570</pub-id></mixed-citation></ref><ref id="imm13012-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="imm13012-cit-0050">
<string-name>
<surname>Proserpio</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Lonnberg</surname>
<given-names>T</given-names>
</string-name>. <article-title>Single&#x02010;cell technologies are revolutionizing the approach to rare cells</article-title>. <source xml:lang="en">Immunol Cell Biol</source>
<year>2016</year>; <volume>94</volume>:<fpage>225</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">26620630</pub-id></mixed-citation></ref><ref id="imm13012-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="imm13012-cit-0051">
<string-name>
<surname>Tarte</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Zhan</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>De Vos</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Klein</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Shaughnessy</surname>
<given-names>J</given-names>
<suffix>Jr</suffix>
</string-name>. <article-title>Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B&#x02010;cell differentiation</article-title>. <source xml:lang="en">Blood</source>
<year>2003</year>; <volume>102</volume>:<fpage>592</fpage>&#x02013;<lpage>600</lpage>.<pub-id pub-id-type="pmid">12663452</pub-id></mixed-citation></ref><ref id="imm13012-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="imm13012-cit-0052">
<string-name>
<surname>Patil</surname>
<given-names>VS</given-names>
</string-name>, <string-name>
<surname>Madrigal</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Schmiedel</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Clarke</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>O'Rourke</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>de Silva</surname>
<given-names>AD</given-names>
</string-name>
<italic>et al</italic>
<article-title>Precursors of human CD4<sup>+</sup> cytotoxic T lymphocytes identified by single&#x02010;cell transcriptome analysis</article-title>. <source xml:lang="en">Sci Immunol</source>
<year>2018</year>; <volume>3</volume>:<fpage>pii: eaan8664</fpage>.</mixed-citation></ref><ref id="imm13012-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="imm13012-cit-0053">
<string-name>
<surname>Brodie</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Tosevski</surname>
<given-names>V</given-names>
</string-name>. <article-title>Broad immune monitoring and profiling of T cell subsets with mass cytometry</article-title>. <source xml:lang="en">Methods Mol Biol</source>
<year>2018</year>; <volume>1745</volume>:<fpage>67</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="pmid">29476463</pub-id></mixed-citation></ref><ref id="imm13012-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="imm13012-cit-0054">
<string-name>
<surname>van Unen</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Molendijk</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Temurhan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hollt</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>van der Meulen&#x02010;de Jong</surname>
<given-names>AE</given-names>
</string-name>
<italic>et al</italic>
<article-title>Mass cytometry of the human mucosal immune system identifies tissue&#x02010; and disease&#x02010;associated immune subsets</article-title>. <source xml:lang="en">Immunity</source>
<year>2016</year>; <volume>44</volume>:<fpage>1227</fpage>&#x02013;<lpage>39</lpage>.<pub-id pub-id-type="pmid">27178470</pub-id></mixed-citation></ref><ref id="imm13012-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="imm13012-cit-0055">
<string-name>
<surname>Georgiou</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Ippolito</surname>
<given-names>GC</given-names>
</string-name>, <string-name>
<surname>Beausang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Busse</surname>
<given-names>CE</given-names>
</string-name>, <string-name>
<surname>Wardemann</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Quake</surname>
<given-names>SR</given-names>
</string-name>. <article-title>The promise and challenge of high&#x02010;throughput sequencing of the antibody repertoire</article-title>. <source xml:lang="en">Nat Biotechnol</source>
<year>2014</year>; <volume>32</volume>:<fpage>158</fpage>&#x02013;<lpage>68</lpage>.<pub-id pub-id-type="pmid">24441474</pub-id></mixed-citation></ref><ref id="imm13012-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="imm13012-cit-0056">
<string-name>
<surname>Corti</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Sallusto</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Lanzavecchia</surname>
<given-names>A</given-names>
</string-name>. <article-title>High throughput cellular screens to interrogate the human T and B cell repertoires</article-title>. <source xml:lang="en">Curr Opin Immunol</source>
<year>2011</year>; <volume>23</volume>:<fpage>430</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">21600751</pub-id></mixed-citation></ref><ref id="imm13012-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="imm13012-cit-0057">
<string-name>
<surname>Becattini</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Latorre</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Mele</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Foglierini</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>De Gregorio</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Cassotta</surname>
<given-names>A</given-names>
</string-name>
<italic>et al</italic>
<article-title>T cell immunity. Functional heterogeneity of human memory CD4<sup>+</sup> T cell clones primed by pathogens or vaccines</article-title>. <source xml:lang="en">Science</source>
<year>2015</year>; <volume>347</volume>:<fpage>400</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">25477212</pub-id></mixed-citation></ref><ref id="imm13012-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="imm13012-cit-0058">
<string-name>
<surname>Moise</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>McMurry</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Buus</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Frey</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Martin</surname>
<given-names>WD</given-names>
</string-name>, <string-name>
<surname>De Groot</surname>
<given-names>AS</given-names>
</string-name>. <article-title>
<italic>In silico</italic>&#x02010;accelerated identification of conserved and immunogenic variola/vaccinia T&#x02010;cell epitopes</article-title>. <source xml:lang="en">Vaccine</source>
<year>2009</year>; <volume>27</volume>:<fpage>6471</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">19559119</pub-id></mixed-citation></ref><ref id="imm13012-bib-0059"><label>59</label><mixed-citation publication-type="journal" id="imm13012-cit-0059">
<string-name>
<surname>Raeven</surname>
<given-names>RHM</given-names>
</string-name>, <string-name>
<surname>van der Maas</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Tilstra</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Uittenbogaard</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Bindels</surname>
<given-names>TH</given-names>
</string-name>, <string-name>
<surname>Kuipers</surname>
<given-names>B</given-names>
</string-name>
<italic>et al</italic>
<article-title>Immunoproteomic profiling of <italic>Bordetella pertussis</italic> outer membrane vesicle vaccine reveals broad and balanced humoral immunogenicity</article-title>. <source xml:lang="en">J Proteome Res</source>
<year>2015</year>; <volume>14</volume>:<fpage>2929</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="pmid">25988566</pub-id></mixed-citation></ref><ref id="imm13012-bib-0060"><label>60</label><mixed-citation publication-type="journal" id="imm13012-cit-0060">
<string-name>
<surname>Legutki</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Johnston</surname>
<given-names>SA</given-names>
</string-name>. <article-title>Immunosignatures can predict vaccine efficacy</article-title>. <source xml:lang="en">Proc Natl Acad Sci U S A</source>
<year>2013</year>; <volume>110</volume>:<fpage>18614</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">24167296</pub-id></mixed-citation></ref><ref id="imm13012-bib-0061"><label>61</label><mixed-citation publication-type="journal" id="imm13012-cit-0061">
<string-name>
<surname>Wrammert</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Koutsonanos</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Edupuganti</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sui</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Morrissey</surname>
<given-names>M</given-names>
</string-name>
<italic>et al</italic>
<article-title>Broadly cross&#x02010;reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection</article-title>. <source xml:lang="en">J Exp Med</source>
<year>2011</year>; <volume>208</volume>:<fpage>181</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="pmid">21220454</pub-id></mixed-citation></ref><ref id="imm13012-bib-0062"><label>62</label><mixed-citation publication-type="journal" id="imm13012-cit-0062">
<string-name>
<surname>Li</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Chiu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wrammert</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>McCausland</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Andrews</surname>
<given-names>SF</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>NY</given-names>
</string-name>
<italic>et al</italic>
<article-title>Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross&#x02010;reactive memory B cells</article-title>. <source xml:lang="en">Proc Natl Acad Sci U S A</source>
<year>2012</year>; <volume>109</volume>:<fpage>9047</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="pmid">22615367</pub-id></mixed-citation></ref><ref id="imm13012-bib-0063"><label>63</label><mixed-citation publication-type="journal" id="imm13012-cit-0063">
<string-name>
<surname>Corti</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Voss</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gamblin</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Codoni</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Macagno</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Jarrossay</surname>
<given-names>D</given-names>
</string-name>
<italic>et al</italic>
<article-title>A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins</article-title>. <source xml:lang="en">Science</source>
<year>2011</year>; <volume>333</volume>:<fpage>850</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">21798894</pub-id></mixed-citation></ref><ref id="imm13012-bib-0064"><label>64</label><mixed-citation publication-type="journal" id="imm13012-cit-0064">
<string-name>
<surname>Pappas</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Foglierini</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Piccoli</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Kallewaard</surname>
<given-names>NL</given-names>
</string-name>, <string-name>
<surname>Turrini</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Silacci</surname>
<given-names>C</given-names>
</string-name>
<italic>et al</italic>
<article-title>Rapid development of broadly influenza neutralizing antibodies through redundant mutations</article-title>. <source xml:lang="en">Nature</source>
<year>2014</year>; <volume>516</volume>:<fpage>418</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">25296253</pub-id></mixed-citation></ref><ref id="imm13012-bib-0065"><label>65</label><mixed-citation publication-type="journal" id="imm13012-cit-0065">
<string-name>
<surname>Corti</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Lanzavecchia</surname>
<given-names>A</given-names>
</string-name>. <article-title>Broadly neutralizing antiviral antibodies</article-title>. <source xml:lang="en">Annu Rev Immunol</source>
<year>2013</year>; <volume>31</volume>:<fpage>705</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="pmid">23330954</pub-id></mixed-citation></ref><ref id="imm13012-bib-0066"><label>66</label><mixed-citation publication-type="journal" id="imm13012-cit-0066">
<string-name>
<surname>Plotkin</surname>
<given-names>SA</given-names>
</string-name>. <article-title>Correlates of protection induced by vaccination</article-title>. <source xml:lang="en">Clin Vaccine Immunol</source>
<year>2010</year>; <volume>17</volume>:<fpage>1055</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="pmid">20463105</pub-id></mixed-citation></ref><ref id="imm13012-bib-0067"><label>67</label><mixed-citation publication-type="journal" id="imm13012-cit-0067">
<string-name>
<surname>Lu</surname>
<given-names>LL</given-names>
</string-name>, <string-name>
<surname>Suscovich</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Fortune</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Alter</surname>
<given-names>G</given-names>
</string-name>. <article-title>Beyond binding: antibody effector functions in infectious diseases</article-title>. <source xml:lang="en">Nat Rev Immunol</source>
<year>2018</year>; <volume>18</volume>:<fpage>46</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="pmid">29063907</pub-id></mixed-citation></ref><ref id="imm13012-bib-0068"><label>68</label><mixed-citation publication-type="journal" id="imm13012-cit-0068">
<string-name>
<surname>Mahan</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Jennewein</surname>
<given-names>MF</given-names>
</string-name>, <string-name>
<surname>Suscovich</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Dionne</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Tedesco</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chung</surname>
<given-names>AW</given-names>
</string-name>
<italic>et al</italic>
<article-title>Antigen&#x02010;specific antibody glycosylation is regulated via vaccination</article-title>. <source xml:lang="en">PLoS Pathog</source>
<year>2016</year>; <volume>12</volume>:<fpage>e1005456</fpage>.<pub-id pub-id-type="pmid">26982805</pub-id></mixed-citation></ref><ref id="imm13012-bib-0069"><label>69</label><mixed-citation publication-type="journal" id="imm13012-cit-0069">
<string-name>
<surname>Selman</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>de Jong</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Soonawala</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Kroon</surname>
<given-names>FP</given-names>
</string-name>, <string-name>
<surname>Adegnika</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Deelder</surname>
<given-names>AM</given-names>
</string-name>
<italic>et al</italic>
<article-title>Changes in antigen&#x02010;specific IgG1 Fc N&#x02010;glycosylation upon influenza and tetanus vaccination</article-title>. <source xml:lang="en">Mol Cell Proteomics</source>
<year>2012</year>; <volume>11</volume>:<fpage>M111 014563</fpage>.</mixed-citation></ref><ref id="imm13012-bib-0070"><label>70</label><mixed-citation publication-type="journal" id="imm13012-cit-0070">
<string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Balog</surname>
<given-names>CI</given-names>
</string-name>, <string-name>
<surname>Stavenhagen</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Koeleman</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Scherer</surname>
<given-names>HU</given-names>
</string-name>, <string-name>
<surname>Selman</surname>
<given-names>MH</given-names>
</string-name>
<italic>et al</italic>
<article-title>Fc&#x02010;glycosylation of IgG1 is modulated by B&#x02010;cell stimuli</article-title>. <source xml:lang="en">Mol Cell Proteomics</source>
<year>2011</year>; <volume>10</volume>:<fpage>M110 004655</fpage>.</mixed-citation></ref><ref id="imm13012-bib-0071"><label>71</label><mixed-citation publication-type="journal" id="imm13012-cit-0071">
<string-name>
<surname>Ackerman</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Barouch</surname>
<given-names>DH</given-names>
</string-name>, <string-name>
<surname>Alter</surname>
<given-names>G</given-names>
</string-name>. <article-title>Systems serology for evaluation of HIV vaccine trials</article-title>. <source xml:lang="en">Immunol Rev</source>
<year>2017</year>; <volume>275</volume>:<fpage>262</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">28133810</pub-id></mixed-citation></ref><ref id="imm13012-bib-0072"><label>72</label><mixed-citation publication-type="journal" id="imm13012-cit-0072">
<string-name>
<surname>Arnold</surname>
<given-names>KB</given-names>
</string-name>, <string-name>
<surname>Chung</surname>
<given-names>AW</given-names>
</string-name>. <article-title>Prospects from systems serology research</article-title>. <source xml:lang="en">Immunology</source>
<year>2018</year>; <volume>153</volume>:<fpage>279</fpage>&#x02013;<lpage>89</lpage>.<pub-id pub-id-type="pmid">29139548</pub-id></mixed-citation></ref><ref id="imm13012-bib-0073"><label>73</label><mixed-citation publication-type="journal" id="imm13012-cit-0073">
<string-name>
<surname>Chung</surname>
<given-names>AW</given-names>
</string-name>, <string-name>
<surname>Kumar</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Arnold</surname>
<given-names>KB</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>WH</given-names>
</string-name>, <string-name>
<surname>Schoen</surname>
<given-names>MK</given-names>
</string-name>, <string-name>
<surname>Dunphy</surname>
<given-names>LJ</given-names>
</string-name>
<italic>et al</italic>
<article-title>Dissecting polyclonal vaccine&#x02010;induced humoral immunity against HIV using systems serology</article-title>. <source xml:lang="en">Cell</source>
<year>2015</year>; <volume>163</volume>:<fpage>988</fpage>&#x02013;<lpage>98</lpage>.<pub-id pub-id-type="pmid">26544943</pub-id></mixed-citation></ref><ref id="imm13012-bib-0074"><label>74</label><mixed-citation publication-type="journal" id="imm13012-cit-0074">
<string-name>
<surname>Weiner</surname>
<given-names>J</given-names>
<suffix>3rd</suffix>
</string-name>, <string-name>
<surname>Kaufmann</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Maertzdorf</surname>
<given-names>J</given-names>
</string-name>. <article-title>High&#x02010;throughput data analysis and data integration for vaccine trials</article-title>. <source xml:lang="en">Vaccine</source>
<year>2015</year>; <volume>33</volume>:<fpage>5249</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="pmid">25976544</pub-id></mixed-citation></ref><ref id="imm13012-bib-0075"><label>75</label><mixed-citation publication-type="journal" id="imm13012-cit-0075">
<string-name>
<surname>Nakaya</surname>
<given-names>HI</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Pulendran</surname>
<given-names>B</given-names>
</string-name>. <article-title>Systems vaccinology: learning to compute the behavior of vaccine induced immunity</article-title>. <source xml:lang="en">Wiley Interdiscip Rev Syst Biol Med</source>
<year>2012</year>; <volume>4</volume>:<fpage>193</fpage>&#x02013;<lpage>205</lpage>.<pub-id pub-id-type="pmid">22012654</pub-id></mixed-citation></ref><ref id="imm13012-bib-0076"><label>76</label><mixed-citation publication-type="journal" id="imm13012-cit-0076">
<string-name>
<surname>Ren</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hinzman</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Kang</surname>
<given-names>EL</given-names>
</string-name>, <string-name>
<surname>Szczesniak</surname>
<given-names>RD</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>LJ</given-names>
</string-name>. <article-title>Computational and statistical analysis of metabolomics data</article-title>. <source xml:lang="en">Metabolomics</source>
<year>2015</year>; <volume>11</volume>:<fpage>1492</fpage>&#x02013;<lpage>513</lpage>.</mixed-citation></ref><ref id="imm13012-bib-0077"><label>77</label><mixed-citation publication-type="journal" id="imm13012-cit-0077">
<string-name>
<surname>Shannon</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Markiel</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ozier</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Baliga</surname>
<given-names>NS</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>JT</given-names>
</string-name>, <string-name>
<surname>Ramage</surname>
<given-names>D</given-names>
</string-name>
<italic>et al</italic>
<article-title>Cytoscape: a software environment for integrated models of biomolecular interaction networks</article-title>. <source xml:lang="en">Genome Res</source>
<year>2003</year>; <volume>13</volume>:<fpage>2498</fpage>&#x02013;<lpage>504</lpage>.<pub-id pub-id-type="pmid">14597658</pub-id></mixed-citation></ref><ref id="imm13012-bib-0078"><label>78</label><mixed-citation publication-type="journal" id="imm13012-cit-0078">
<string-name>
<surname>Raeven</surname>
<given-names>RHM</given-names>
</string-name>, <string-name>
<surname>Pennings</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>van Riet</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kersten</surname>
<given-names>GF</given-names>
</string-name>, <string-name>
<surname>Metz</surname>
<given-names>B</given-names>
</string-name>. <article-title>Meta&#x02010;Analysis of pulmonary transcriptomes from differently primed mice identifies molecular signatures to differentiate immune responses following bordetella pertussis challenge</article-title>. <source xml:lang="en">J Immunol Res</source>
<year>2017</year>; <volume>2017</volume>:<fpage>8512847</fpage>.<pub-id pub-id-type="pmid">28243609</pub-id></mixed-citation></ref><ref id="imm13012-bib-0079"><label>79</label><mixed-citation publication-type="journal" id="imm13012-cit-0079">
<string-name>
<surname>Li</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Rouphael</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Duraisingham</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Romero&#x02010;Steiner</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Presnell</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Davis</surname>
<given-names>C</given-names>
</string-name>
<italic>et al</italic>
<article-title>Molecular signatures of antibody responses derived from a systems biology study of five human vaccines</article-title>. <source xml:lang="en">Nat Immunol</source>
<year>2014</year>; <volume>15</volume>:<fpage>195</fpage>&#x02013;<lpage>204</lpage>.<pub-id pub-id-type="pmid">24336226</pub-id></mixed-citation></ref><ref id="imm13012-bib-0080"><label>80</label><mixed-citation publication-type="journal" id="imm13012-cit-0080">
<string-name>
<surname>van Unen</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Hollt</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Pezzotti</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Reinders</surname>
<given-names>MJT</given-names>
</string-name>, <string-name>
<surname>Eisemann</surname>
<given-names>E</given-names>
</string-name>
<italic>et al</italic>
<article-title>Visual analysis of mass cytometry data by hierarchical stochastic neighbour embedding reveals rare cell types</article-title>. <source xml:lang="en">Nat Commun</source>
<year>2017</year>; <volume>8</volume>:<fpage>1740</fpage>.<pub-id pub-id-type="pmid">29170529</pub-id></mixed-citation></ref><ref id="imm13012-bib-0081"><label>81</label><mixed-citation publication-type="journal" id="imm13012-cit-0081">
<string-name>
<surname>Kidd</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Peters</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Schadt</surname>
<given-names>EE</given-names>
</string-name>, <string-name>
<surname>Dudley</surname>
<given-names>JT</given-names>
</string-name>. <article-title>Unifying immunology with informatics and multiscale biology</article-title>. <source xml:lang="en">Nat Immunol</source>
<year>2014</year>; <volume>15</volume>:<fpage>118</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="pmid">24448569</pub-id></mixed-citation></ref><ref id="imm13012-bib-0082"><label>82</label><mixed-citation publication-type="journal" id="imm13012-cit-0082">
<string-name>
<surname>da Huang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Sherman</surname>
<given-names>BT</given-names>
</string-name>, <string-name>
<surname>Lempicki</surname>
<given-names>RA</given-names>
</string-name>. <article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title>. <source xml:lang="en">Nat Protoc</source>
<year>2009</year>; <volume>4</volume>:<fpage>44</fpage>&#x02013;<lpage>57</lpage>.<pub-id pub-id-type="pmid">19131956</pub-id></mixed-citation></ref><ref id="imm13012-bib-0083"><label>83</label><mixed-citation publication-type="journal" id="imm13012-cit-0083">
<string-name>
<surname>Draghici</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Khatri</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Tarca</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Amin</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Done</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Voichita</surname>
<given-names>C</given-names>
</string-name>
<italic>et al</italic>
<article-title>A systems biology approach for pathway level analysis</article-title>. <source xml:lang="en">Genome Res</source>
<year>2007</year>; <volume>17</volume>:<fpage>1537</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="pmid">17785539</pub-id></mixed-citation></ref><ref id="imm13012-bib-0084"><label>84</label><mixed-citation publication-type="journal" id="imm13012-cit-0084">
<string-name>
<surname>Ashburner</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ball</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Blake</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Botstein</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Butler</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Cherry</surname>
<given-names>JM</given-names>
</string-name>
<italic>et al</italic>
<article-title>Gene ontology: tool for the unification of biology. The gene ontology consortium</article-title>. <source xml:lang="en">Nat Genet</source>
<year>2000</year>; <volume>25</volume>:<fpage>25</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">10802651</pub-id></mixed-citation></ref><ref id="imm13012-bib-0085"><label>85</label><mixed-citation publication-type="journal" id="imm13012-cit-0085">
<string-name>
<surname>Ogata</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Goto</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sato</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Fujibuchi</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Bono</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kanehisa</surname>
<given-names>M</given-names>
</string-name>. <article-title>KEGG: Kyoto encyclopedia of genes and genomes</article-title>. <source xml:lang="en">Nucleic Acids Res</source>
<year>1999</year>; <volume>27</volume>:<fpage>29</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="pmid">9847135</pub-id></mixed-citation></ref><ref id="imm13012-bib-0086"><label>86</label><mixed-citation publication-type="journal" id="imm13012-cit-0086">
<string-name>
<surname>Wu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Orozco</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Boyer</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Leglise</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Goodale</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Batalov</surname>
<given-names>S</given-names>
</string-name>
<italic>et al</italic>
<article-title>BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources</article-title>. <source xml:lang="en">Genome Biol</source>
<year>2009</year>; <volume>10</volume>:<fpage>R130</fpage>.<pub-id pub-id-type="pmid">19919682</pub-id></mixed-citation></ref><ref id="imm13012-bib-0087"><label>87</label><mixed-citation publication-type="journal" id="imm13012-cit-0087">
<string-name>
<surname>Lynn</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Winsor</surname>
<given-names>GL</given-names>
</string-name>, <string-name>
<surname>Chan</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Richard</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Laird</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Barsky</surname>
<given-names>A</given-names>
</string-name>
<italic>et al</italic>
<article-title>InnateDB: facilitating systems&#x02010;level analyses of the mammalian innate immune response</article-title>. <source xml:lang="en">Mol Syst Biol</source>
<year>2008</year>; <volume>4</volume>:<fpage>218</fpage>.<pub-id pub-id-type="pmid">18766178</pub-id></mixed-citation></ref><ref id="imm13012-bib-0088"><label>88</label><mixed-citation publication-type="journal" id="imm13012-cit-0088">
<string-name>
<surname>Samarajiwa</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Forster</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Auchettl</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hertzog</surname>
<given-names>PJ</given-names>
</string-name>. <article-title>INTERFEROME: the database of interferon regulated genes</article-title>. <source xml:lang="en">Nucleic Acids Res</source>
<year>2009</year>; <volume>37</volume>(<issue>Database issue</issue>):<fpage>D852</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">18996892</pub-id></mixed-citation></ref><ref id="imm13012-bib-0089"><label>89</label><mixed-citation publication-type="journal" id="imm13012-cit-0089">
<string-name>
<surname>Russo</surname>
<given-names>PST</given-names>
</string-name>, <string-name>
<surname>Ferreira</surname>
<given-names>GR</given-names>
</string-name>, <string-name>
<surname>Cardozo</surname>
<given-names>LE</given-names>
</string-name>, <string-name>
<surname>Burger</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Arias&#x02010;Carrasco</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Maruyama</surname>
<given-names>SR</given-names>
</string-name>
<italic>et al</italic>
<article-title>CEMiTool: a Bioconductor package for performing comprehensive modular co&#x02010;expression analyses</article-title>. <source xml:lang="en">BMC Bioinformatics</source>
<year>2018</year>; <volume>19</volume>:<fpage>56</fpage>.<pub-id pub-id-type="pmid">29458351</pub-id></mixed-citation></ref><ref id="imm13012-bib-0090"><label>90</label><mixed-citation publication-type="journal" id="imm13012-cit-0090">
<string-name>
<surname>Bagaev</surname>
<given-names>DV</given-names>
</string-name>, <string-name>
<surname>Zvyagin</surname>
<given-names>IV</given-names>
</string-name>, <string-name>
<surname>Putintseva</surname>
<given-names>EV</given-names>
</string-name>, <string-name>
<surname>Izraelson</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Britanova</surname>
<given-names>OV</given-names>
</string-name>, <string-name>
<surname>Chudakov</surname>
<given-names>DM</given-names>
</string-name>
<italic>et al</italic>
<article-title>VDJviz: a versatile browser for immunogenomics data</article-title>. <source xml:lang="en">BMC Genom</source>
<year>2016</year>; <volume>17</volume>:<fpage>453</fpage>.</mixed-citation></ref><ref id="imm13012-bib-0091"><label>91</label><mixed-citation publication-type="journal" id="imm13012-cit-0091">
<string-name>
<surname>Shugay</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bagaev</surname>
<given-names>DV</given-names>
</string-name>, <string-name>
<surname>Zvyagin</surname>
<given-names>IV</given-names>
</string-name>, <string-name>
<surname>Vroomans</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Crawford</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Dolton</surname>
<given-names>G</given-names>
</string-name>
<italic>et al</italic>
<article-title>VDJdb: a curated database of T&#x02010;cell receptor sequences with known antigen specificity</article-title>. <source xml:lang="en">Nucleic Acids Res</source>
<year>2018</year>; <volume>46</volume>(<issue>D1</issue>):<fpage>D419</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="pmid">28977646</pub-id></mixed-citation></ref><ref id="imm13012-bib-0092"><label>92</label><mixed-citation publication-type="journal" id="imm13012-cit-0092">
<string-name>
<surname>Wooden</surname>
<given-names>SL</given-names>
</string-name>, <string-name>
<surname>Koff</surname>
<given-names>WC</given-names>
</string-name>. <article-title>The Human Vaccines Project: towards a comprehensive understanding of the human immune response to immunization</article-title>. <source xml:lang="en">Hum Vaccin Immunother</source>
<year>2018</year>; <volume>14</volume>:<fpage>2214</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">29847214</pub-id></mixed-citation></ref><ref id="imm13012-bib-0093"><label>93</label><mixed-citation publication-type="journal" id="imm13012-cit-0093">
<string-name>
<surname>Kitano</surname>
<given-names>H</given-names>
</string-name>. <article-title>Computational systems biology</article-title>. <source xml:lang="en">Nature</source>
<year>2002</year>; <volume>420</volume>:<fpage>206</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="pmid">12432404</pub-id></mixed-citation></ref><ref id="imm13012-bib-0094"><label>94</label><mixed-citation publication-type="journal" id="imm13012-cit-0094">
<string-name>
<surname>Wang</surname>
<given-names>HW</given-names>
</string-name>, <string-name>
<surname>Pai</surname>
<given-names>TW</given-names>
</string-name>. <article-title>Machine learning&#x02010;based methods for prediction of linear B&#x02010;cell epitopes</article-title>. <source xml:lang="en">Methods Mol Biol</source>
<year>2014</year>; <volume>1184</volume>:<fpage>217</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="pmid">25048127</pub-id></mixed-citation></ref><ref id="imm13012-bib-0095"><label>95</label><mixed-citation publication-type="journal" id="imm13012-cit-0095">
<string-name>
<surname>Desai</surname>
<given-names>DV</given-names>
</string-name>, <string-name>
<surname>Kulkarni&#x02010;Kale</surname>
<given-names>U</given-names>
</string-name>. <article-title>T&#x02010;cell epitope prediction methods: an overview</article-title>. <source xml:lang="en">Methods Mol Biol</source>
<year>2014</year>; <volume>1184</volume>:<fpage>333</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="pmid">25048134</pub-id></mixed-citation></ref><ref id="imm13012-bib-0096"><label>96</label><mixed-citation publication-type="journal" id="imm13012-cit-0096">
<string-name>
<surname>Gupta</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Mittal</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Madhu</surname>
<given-names>MK</given-names>
</string-name>, <string-name>
<surname>Sharma</surname>
<given-names>VK</given-names>
</string-name>. <article-title>IL17eScan: a Tool for the Identification of Peptides Inducing IL&#x02010;17 Response</article-title>. <source xml:lang="en">Front Immunol</source>
<year>2017</year>; <volume>8</volume>:<fpage>1430</fpage>.<pub-id pub-id-type="pmid">29163505</pub-id></mixed-citation></ref><ref id="imm13012-bib-0097"><label>97</label><mixed-citation publication-type="journal" id="imm13012-cit-0097">
<string-name>
<surname>Metz</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Hoonakker</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Uittenbogaard</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Weyts</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mommen</surname>
<given-names>GP</given-names>
</string-name>, <string-name>
<surname>Meiring</surname>
<given-names>HD</given-names>
</string-name>
<italic>et al</italic>
<article-title>Proteome analysis is a valuable tool to monitor antigen expression during upstream processing of whole&#x02010;cell pertussis vaccines</article-title>. <source xml:lang="en">J Proteome Res</source>
<year>2017</year>; <volume>16</volume>:<fpage>528</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="pmid">27977922</pub-id></mixed-citation></ref><ref id="imm13012-bib-0098"><label>98</label><mixed-citation publication-type="journal" id="imm13012-cit-0098">
<string-name>
<surname>Smith</surname>
<given-names>CL</given-names>
</string-name>, <string-name>
<surname>Dickinson</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Forster</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Craigon</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ross</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Khondoker</surname>
<given-names>MR</given-names>
</string-name>
<italic>et al</italic>
<article-title>Identification of a human neonatal immune&#x02010;metabolic network associated with bacterial infection</article-title>. <source xml:lang="en">Nat Commun</source>
<year>2014</year>; <volume>5</volume>:<fpage>4649</fpage>.<pub-id pub-id-type="pmid">25120092</pub-id></mixed-citation></ref><ref id="imm13012-bib-0099"><label>99</label><mixed-citation publication-type="journal" id="imm13012-cit-0099">
<string-name>
<surname>Pennings</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Schuurhof</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hodemaekers</surname>
<given-names>HM</given-names>
</string-name>, <string-name>
<surname>Buisman</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>de Rond</surname>
<given-names>LC</given-names>
</string-name>, <string-name>
<surname>Widjojoatmodjo</surname>
<given-names>MN</given-names>
</string-name>
<italic>et al</italic>
<article-title>Systemic signature of the lung response to respiratory syncytial virus infection</article-title>. <source xml:lang="en">PLoS ONE</source>
<year>2011</year>; <volume>6</volume>:<fpage>e21461</fpage>.<pub-id pub-id-type="pmid">21731757</pub-id></mixed-citation></ref><ref id="imm13012-bib-0100"><label>100</label><mixed-citation publication-type="journal" id="imm13012-cit-0100">
<string-name>
<surname>Mejias</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Dimo</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Suarez</surname>
<given-names>NM</given-names>
</string-name>, <string-name>
<surname>Garcia</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Suarez&#x02010;Arrabal</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Jartti</surname>
<given-names>T</given-names>
</string-name>
<italic>et al</italic>
<article-title>Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection</article-title>. <source xml:lang="en">PLoS Med</source>
<year>2013</year>; <volume>10</volume>:<fpage>e1001549</fpage>.<pub-id pub-id-type="pmid">24265599</pub-id></mixed-citation></ref><ref id="imm13012-bib-0101"><label>101</label><mixed-citation publication-type="journal" id="imm13012-cit-0101">
<string-name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Jamaluddin</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ivanciuc</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Garofalo</surname>
<given-names>RP</given-names>
</string-name>
<italic>et al</italic>
<article-title>Systematic analysis of cell&#x02010;type differences in the epithelial secretome reveals insights into the pathogenesis of respiratory syncytial virus&#x02010;induced lower respiratory tract infections</article-title>. <source xml:lang="en">J Immunol</source>
<year>2017</year>; <volume>198</volume>:<fpage>3345</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="pmid">28258195</pub-id></mixed-citation></ref><ref id="imm13012-bib-0102"><label>102</label><mixed-citation publication-type="journal" id="imm13012-cit-0102">
<string-name>
<surname>Berry</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Graham</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>McNab</surname>
<given-names>FW</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Bloch</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Oni</surname>
<given-names>T</given-names>
</string-name>
<italic>et al</italic>
<article-title>An interferon&#x02010;inducible neutrophil&#x02010;driven blood transcriptional signature in human tuberculosis</article-title>. <source xml:lang="en">Nature</source>
<year>2010</year>; <volume>466</volume>:<fpage>973</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">20725040</pub-id></mixed-citation></ref><ref id="imm13012-bib-0103"><label>103</label><mixed-citation publication-type="journal" id="imm13012-cit-0103">
<string-name>
<surname>Banus</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Pennings</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Vandebriel</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Wester</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Breit</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Mooi</surname>
<given-names>F</given-names>
</string-name>
<italic>et al</italic>
<article-title>Lung response to <italic>Bordetella pertussis</italic> infection in mice identified by gene&#x02010;expression profiling</article-title>. <source xml:lang="en">Immunogenetics</source>
<year>2007</year>; <volume>59</volume>:<fpage>555</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="pmid">17487483</pub-id></mixed-citation></ref><ref id="imm13012-bib-0104"><label>104</label><mixed-citation publication-type="journal" id="imm13012-cit-0104">
<string-name>
<surname>Brandes</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Klauschen</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Kuchen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Germain</surname>
<given-names>RN</given-names>
</string-name>. <article-title>A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection</article-title>. <source xml:lang="en">Cell</source>
<year>2013</year>; <volume>154</volume>:<fpage>197</fpage>&#x02013;<lpage>212</lpage>.<pub-id pub-id-type="pmid">23827683</pub-id></mixed-citation></ref><ref id="imm13012-bib-0105"><label>105</label><mixed-citation publication-type="journal" id="imm13012-cit-0105">
<string-name>
<surname>Tam</surname>
<given-names>VC</given-names>
</string-name>, <string-name>
<surname>Quehenberger</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Oshansky</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Suen</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Armando</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Treuting</surname>
<given-names>PM</given-names>
</string-name>
<italic>et al</italic>
<article-title>Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammation</article-title>. <source xml:lang="en">Cell</source>
<year>2013</year>; <volume>154</volume>:<fpage>213</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="pmid">23827684</pub-id></mixed-citation></ref><ref id="imm13012-bib-0106"><label>106</label><mixed-citation publication-type="journal" id="imm13012-cit-0106">
<string-name>
<surname>Raeven</surname>
<given-names>RHM</given-names>
</string-name>, <string-name>
<surname>Brummelman</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>van der Maas</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Tilstra</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Pennings</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>WG</given-names>
</string-name>
<italic>et al</italic>
<article-title>Immunological signatures after <italic>Bordetella pertussis</italic> infection demonstrate importance of pulmonary innate immune cells</article-title>. <source xml:lang="en">PLoS ONE</source>
<year>2016</year>; <volume>11</volume>:<fpage>e0164027</fpage>.<pub-id pub-id-type="pmid">27711188</pub-id></mixed-citation></ref><ref id="imm13012-bib-0107"><label>107</label><mixed-citation publication-type="journal" id="imm13012-cit-0107">
<string-name>
<surname>Merkel</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Halperin</surname>
<given-names>SA</given-names>
</string-name>. <article-title>Nonhuman primate and human challenge models of pertussis</article-title>. <source xml:lang="en">J Infect Dis</source>
<year>2014</year>; <volume>209</volume>(<issue>Suppl 1</issue>):<fpage>S20</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="pmid">24626867</pub-id></mixed-citation></ref><ref id="imm13012-bib-0108"><label>108</label><mixed-citation publication-type="journal" id="imm13012-cit-0108">
<string-name>
<surname>Harandi</surname>
<given-names>AM</given-names>
</string-name>. <article-title>Systems analysis of human vaccine adjuvants</article-title>. <source xml:lang="en">Semin Immunol</source>
<year>2018</year>; pii: S1044&#x02010;5323(18)30069&#x02010;1. <pub-id pub-id-type="doi">10.1016/j.smim.2018.08.001</pub-id>. [Epub ahead of print]</mixed-citation></ref><ref id="imm13012-bib-0109"><label>109</label><mixed-citation publication-type="journal" id="imm13012-cit-0109">
<string-name>
<surname>Kooijman</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Brummelman</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>van Els</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Marino</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Heck</surname>
<given-names>AJR</given-names>
</string-name>, <string-name>
<surname>Mommen</surname>
<given-names>GPM</given-names>
</string-name>
<italic>et al</italic>
<article-title>Novel identified aluminum hydroxide&#x02010;induced pathways prove monocyte activation and pro&#x02010;inflammatory preparedness</article-title>. <source xml:lang="en">J Proteomics</source>
<year>2018</year>; <volume>175</volume>:<fpage>144</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="pmid">29317357</pub-id></mixed-citation></ref><ref id="imm13012-bib-0110"><label>110</label><mixed-citation publication-type="journal" id="imm13012-cit-0110">
<string-name>
<surname>Hancock</surname>
<given-names>DG</given-names>
</string-name>, <string-name>
<surname>Shklovskaya</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Guy</surname>
<given-names>TV</given-names>
</string-name>, <string-name>
<surname>Falsafi</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Fjell</surname>
<given-names>CD</given-names>
</string-name>, <string-name>
<surname>Ritchie</surname>
<given-names>W</given-names>
</string-name>
<italic>et al</italic>
<article-title>A systems biology approach to the analysis of subset&#x02010;specific responses to lipopolysaccharide in dendritic cells</article-title>. <source xml:lang="en">PLoS ONE</source>
<year>2014</year>; <volume>9</volume>:<fpage>e100613</fpage>.<pub-id pub-id-type="pmid">24949855</pub-id></mixed-citation></ref><ref id="imm13012-bib-0111"><label>111</label><mixed-citation publication-type="journal" id="imm13012-cit-0111">
<string-name>
<surname>Olafsdottir</surname>
<given-names>TA</given-names>
</string-name>, <string-name>
<surname>Lindqvist</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nookaew</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Andersen</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Maertzdorf</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Persson</surname>
<given-names>J</given-names>
</string-name>
<italic>et al</italic>
<article-title>Comparative systems analyses reveal molecular signatures of clinically tested vaccine adjuvants</article-title>. <source xml:lang="en">Sci Rep</source>
<year>2016</year>; <volume>6</volume>:<fpage>39097</fpage>.<pub-id pub-id-type="pmid">27958370</pub-id></mixed-citation></ref><ref id="imm13012-bib-0112"><label>112</label><mixed-citation publication-type="journal" id="imm13012-cit-0112">
<string-name>
<surname>Santoro</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Pettini</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kazmin</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Ciabattini</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Fiorino</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Gilfillan</surname>
<given-names>GD</given-names>
</string-name>
<italic>et al</italic>
<article-title>Transcriptomics of the vaccine immune response: priming with adjuvant modulates recall innate responses after boosting</article-title>. <source xml:lang="en">Front Immunol</source>
<year>2018</year>; <volume>9</volume>:<fpage>1248</fpage>.<pub-id pub-id-type="pmid">29922291</pub-id></mixed-citation></ref><ref id="imm13012-bib-0113"><label>113</label><mixed-citation publication-type="journal" id="imm13012-cit-0113">
<string-name>
<surname>Lindqvist</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nookaew</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Brinkenberg</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Samuelson</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Thorn</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Nielsen</surname>
<given-names>J</given-names>
</string-name>
<italic>et al</italic>
<article-title>Unraveling molecular signatures of immunostimulatory adjuvants in the female genital tract through systems biology</article-title>. <source xml:lang="en">PLoS ONE</source>
<year>2011</year>; <volume>6</volume>:<fpage>e20448</fpage>.<pub-id pub-id-type="pmid">21666746</pub-id></mixed-citation></ref><ref id="imm13012-bib-0114"><label>114</label><mixed-citation publication-type="journal" id="imm13012-cit-0114">
<string-name>
<surname>Gomez</surname>
<given-names>CE</given-names>
</string-name>, <string-name>
<surname>Perdiguero</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Jimenez</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Filali&#x02010;Mouhim</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ghneim</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Haddad</surname>
<given-names>EK</given-names>
</string-name>
<italic>et al</italic>
<article-title>Systems analysis of MVA&#x02010;C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C</article-title>. <source xml:lang="en">PLoS ONE</source>
<year>2012</year>; <volume>7</volume>:<fpage>e35485</fpage>.<pub-id pub-id-type="pmid">22536391</pub-id></mixed-citation></ref><ref id="imm13012-bib-0115"><label>115</label><mixed-citation publication-type="journal" id="imm13012-cit-0115">
<string-name>
<surname>Strouts</surname>
<given-names>FR</given-names>
</string-name>, <string-name>
<surname>Popper</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Partidos</surname>
<given-names>CD</given-names>
</string-name>, <string-name>
<surname>Stinchcomb</surname>
<given-names>DT</given-names>
</string-name>, <string-name>
<surname>Osorio</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Relman</surname>
<given-names>DA</given-names>
</string-name>. <article-title>Early transcriptional signatures of the immune response to a live attenuated tetravalent dengue vaccine candidate in non&#x02010;human primates</article-title>. <source xml:lang="en">PLoS Negl Trop Dis</source>
<year>2016</year>; <volume>10</volume>:<fpage>e0004731</fpage>.<pub-id pub-id-type="pmid">27214236</pub-id></mixed-citation></ref><ref id="imm13012-bib-0116"><label>116</label><mixed-citation publication-type="journal" id="imm13012-cit-0116">
<string-name>
<surname>Raeven</surname>
<given-names>RHM</given-names>
</string-name>, <string-name>
<surname>Brummelman</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Pennings</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>van der Maas</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Tilstra</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Helm</surname>
<given-names>K</given-names>
</string-name>
<italic>et al</italic>
<article-title>
<italic>Bordetella pertussis</italic> outer membrane vesicle vaccine confers equal efficacy in mice with milder inflammatory responses compared to a whole&#x02010;cell vaccine</article-title>. <source xml:lang="en">Sci Rep</source>
<year>2016</year>; <volume>6</volume>:<fpage>38240</fpage>.<pub-id pub-id-type="pmid">27905535</pub-id></mixed-citation></ref><ref id="imm13012-bib-0117"><label>117</label><mixed-citation publication-type="journal" id="imm13012-cit-0117">
<string-name>
<surname>Mizukami</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Momose</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kuramitsu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Takizawa</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Araki</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Furuhata</surname>
<given-names>K</given-names>
</string-name>
<italic>et al</italic>
<article-title>System vaccinology for the evaluation of influenza vaccine safety by multiplex gene detection of novel biomarkers in a preclinical study and batch release test</article-title>. <source xml:lang="en">PLoS ONE</source>
<year>2014</year>; <volume>9</volume>:<fpage>e101835</fpage>.<pub-id pub-id-type="pmid">25010690</pub-id></mixed-citation></ref><ref id="imm13012-bib-0118"><label>118</label><mixed-citation publication-type="journal" id="imm13012-cit-0118">
<string-name>
<surname>Wang</surname>
<given-names>IM</given-names>
</string-name>, <string-name>
<surname>Bett</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Cristescu</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Loboda</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>ter Meulen</surname>
<given-names>J</given-names>
</string-name>. <article-title>Transcriptional profiling of vaccine&#x02010;induced immune responses in humans and non&#x02010;human primates</article-title>. <source xml:lang="en">Microb Biotechnol</source>
<year>2012</year>; <volume>5</volume>:<fpage>177</fpage>&#x02013;<lpage>87</lpage>.<pub-id pub-id-type="pmid">22103427</pub-id></mixed-citation></ref><ref id="imm13012-bib-0119"><label>119</label><mixed-citation publication-type="journal" id="imm13012-cit-0119">
<string-name>
<surname>Lewis</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Lythgoe</surname>
<given-names>MP</given-names>
</string-name>. <article-title>Application of &#x0201c;systems vaccinology&#x0201d; to evaluate inflammation and reactogenicity of adjuvanted preventative vaccines</article-title>. <source xml:lang="en">J Immunol Res</source>
<year>2015</year>; <volume>2015</volume>:<fpage>909406</fpage>.<pub-id pub-id-type="pmid">26380327</pub-id></mixed-citation></ref><ref id="imm13012-bib-0120"><label>120</label><mixed-citation publication-type="journal" id="imm13012-cit-0120">
<string-name>
<surname>Rechtien</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Richert</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Lorenzo</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Martrus</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Hejblum</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Dahlke</surname>
<given-names>C</given-names>
</string-name>
<italic>et al</italic>
<article-title>Systems vaccinology identifies an early innate immune signature as a correlate of antibody responses to the Ebola vaccine rVSV&#x02010;ZEBOV</article-title>. <source xml:lang="en">Cell Rep</source>
<year>2017</year>; <volume>20</volume>:<fpage>2251</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="pmid">28854372</pub-id></mixed-citation></ref><ref id="imm13012-bib-0121"><label>121</label><mixed-citation publication-type="journal" id="imm13012-cit-0121">
<string-name>
<surname>Anderson</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Olafsdottir</surname>
<given-names>TA</given-names>
</string-name>, <string-name>
<surname>Kratochvil</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>McKay</surname>
<given-names>PF</given-names>
</string-name>, <string-name>
<surname>Ostensson</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Persson</surname>
<given-names>J</given-names>
</string-name>
<italic>et al</italic>
<article-title>Molecular signatures of a TLR4 agonist&#x02010;adjuvanted HIV&#x02010;1 vaccine candidate in humans</article-title>. <source xml:lang="en">Front Immunol</source>
<year>2018</year>; <volume>9</volume>:<fpage>301</fpage>.<pub-id pub-id-type="pmid">29535712</pub-id></mixed-citation></ref><ref id="imm13012-bib-0122"><label>122</label><mixed-citation publication-type="journal" id="imm13012-cit-0122">
<string-name>
<surname>Kazmin</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Nakaya</surname>
<given-names>HI</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>EK</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>van der Most</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>van den Berg</surname>
<given-names>RA</given-names>
</string-name>
<italic>et al</italic>
<article-title>Systems analysis of protective immune responses to RTS, S malaria vaccination in humans</article-title>. <source xml:lang="en">Proc Natl Acad Sci U S A</source>
<year>2017</year>; <volume>114</volume>:<fpage>2425</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">28193898</pub-id></mixed-citation></ref><ref id="imm13012-bib-0123"><label>123</label><mixed-citation publication-type="journal" id="imm13012-cit-0123">
<string-name>
<surname>van den Berg</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Coccia</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ballou</surname>
<given-names>WR</given-names>
</string-name>, <string-name>
<surname>Kester</surname>
<given-names>KE</given-names>
</string-name>, <string-name>
<surname>Ockenhouse</surname>
<given-names>CF</given-names>
</string-name>, <string-name>
<surname>Vekemans</surname>
<given-names>J</given-names>
</string-name>
<italic>et al</italic>
<article-title>Predicting RTS, S vaccine&#x02010;mediated protection from transcriptomes in a malaria&#x02010;challenge clinical trial</article-title>. <source xml:lang="en">Front Immunol</source>
<year>2017</year>; <volume>8</volume>:<fpage>557</fpage>.<pub-id pub-id-type="pmid">28588574</pub-id></mixed-citation></ref><ref id="imm13012-bib-0124"><label>124</label><mixed-citation publication-type="journal" id="imm13012-cit-0124">
<string-name>
<surname>van den Berg</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>De Mot</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Leroux&#x02010;Roels</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Bechtold</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Clement</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Coccia</surname>
<given-names>M</given-names>
</string-name>
<italic>et al</italic>
<article-title>Adjuvant&#x02010;associated peripheral blood mRNA profiles and kinetics induced by the adjuvanted recombinant protein candidate tuberculosis vaccine M72/AS01 in bacillus Calmette&#x02013;Gu&#x000e9;rin&#x02010;vaccinated adults</article-title>. <source xml:lang="en">Front Immunol</source>
<year>2018</year>; <volume>9</volume>:<fpage>564</fpage>.<pub-id pub-id-type="pmid">29632533</pub-id></mixed-citation></ref><ref id="imm13012-bib-0125"><label>125</label><mixed-citation publication-type="journal" id="imm13012-cit-0125">
<string-name>
<surname>Howard</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Hoek</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>Goll</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Samir</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Galassie</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Allos</surname>
<given-names>TM</given-names>
</string-name>
<italic>et al</italic>
<article-title>Cell&#x02010;based systems biology analysis of human AS03&#x02010;adjuvanted H5N1 avian influenza vaccine responses: a phase I randomized controlled trial</article-title>. <source xml:lang="en">PLoS ONE</source>
<year>2017</year>; <volume>12</volume>:<fpage>e0167488</fpage>.<pub-id pub-id-type="pmid">28099485</pub-id></mixed-citation></ref><ref id="imm13012-bib-0126"><label>126</label><mixed-citation publication-type="journal" id="imm13012-cit-0126">
<string-name>
<surname>Querec</surname>
<given-names>TD</given-names>
</string-name>, <string-name>
<surname>Akondy</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>EK</given-names>
</string-name>, <string-name>
<surname>Cao</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Nakaya</surname>
<given-names>HI</given-names>
</string-name>, <string-name>
<surname>Teuwen</surname>
<given-names>D</given-names>
</string-name>
<italic>et al</italic>
<article-title>Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans</article-title>. <source xml:lang="en">Nat Immunol</source>
<year>2009</year>; <volume>10</volume>:<fpage>116</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="pmid">19029902</pub-id></mixed-citation></ref><ref id="imm13012-bib-0127"><label>127</label><mixed-citation publication-type="journal" id="imm13012-cit-0127">
<string-name>
<surname>Gaucher</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Therrien</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kettaf</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Angermann</surname>
<given-names>BR</given-names>
</string-name>, <string-name>
<surname>Boucher</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Filali&#x02010;Mouhim</surname>
<given-names>A</given-names>
</string-name>
<italic>et al</italic>
<article-title>Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses</article-title>. <source xml:lang="en">J Exp Med</source>
<year>2008</year>; <volume>205</volume>:<fpage>3119</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">19047440</pub-id></mixed-citation></ref><ref id="imm13012-bib-0128"><label>128</label><mixed-citation publication-type="journal" id="imm13012-cit-0128">
<string-name>
<surname>Nakaya</surname>
<given-names>HI</given-names>
</string-name>, <string-name>
<surname>Clutterbuck</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kazmin</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Cortese</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bosinger</surname>
<given-names>SE</given-names>
</string-name>
<italic>et al</italic>
<article-title>Systems biology of immunity to MF59&#x02010;adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood</article-title>. <source xml:lang="en">Proc Natl Acad Sci U S A</source>
<year>2016</year>; <volume>113</volume>:<fpage>1853</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">26755593</pub-id></mixed-citation></ref><ref id="imm13012-bib-0129"><label>129</label><mixed-citation publication-type="journal" id="imm13012-cit-0129">
<string-name>
<surname>Nakaya</surname>
<given-names>HI</given-names>
</string-name>, <string-name>
<surname>Hagan</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Duraisingham</surname>
<given-names>SS</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>EK</given-names>
</string-name>, <string-name>
<surname>Kwissa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Rouphael</surname>
<given-names>N</given-names>
</string-name>
<italic>et al</italic>
<article-title>Systems analysis of immunity to influenza vaccination across multiple years and in diverse populations reveals shared molecular signatures</article-title>. <source xml:lang="en">Immunity</source>
<year>2015</year>; <volume>43</volume>:<fpage>1186</fpage>&#x02013;<lpage>98</lpage>.<pub-id pub-id-type="pmid">26682988</pub-id></mixed-citation></ref><ref id="imm13012-bib-0130"><label>130</label><mixed-citation publication-type="journal" id="imm13012-cit-0130">
<string-name>
<surname>Fourati</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Cristescu</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Loboda</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Talla</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Filali</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Railkar</surname>
<given-names>R</given-names>
</string-name>
<italic>et al</italic>
<article-title>Pre&#x02010;vaccination inflammation and B&#x02010;cell signalling predict age&#x02010;related hyporesponse to hepatitis B vaccination</article-title>. <source xml:lang="en">Nat Commun</source>
<year>2016</year>; <volume>7</volume>:<fpage>10369</fpage>.<pub-id pub-id-type="pmid">26742691</pub-id></mixed-citation></ref><ref id="imm13012-bib-0131"><label>131</label><mixed-citation publication-type="journal" id="imm13012-cit-0131">
<string-name>
<surname>Voigt</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Grill</surname>
<given-names>DE</given-names>
</string-name>, <string-name>
<surname>Zimmermann</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Simon</surname>
<given-names>WL</given-names>
</string-name>, <string-name>
<surname>Ovsyannikova</surname>
<given-names>IG</given-names>
</string-name>, <string-name>
<surname>Kennedy</surname>
<given-names>RB</given-names>
</string-name>
<italic>et al</italic>
<article-title>Transcriptomic signatures of cellular and humoral immune responses in older adults after seasonal influenza vaccination identified by data&#x02010;driven clustering</article-title>. <source xml:lang="en">Sci Rep</source>
<year>2018</year>; <volume>8</volume>:<fpage>739</fpage>.<pub-id pub-id-type="pmid">29335477</pub-id></mixed-citation></ref><ref id="imm13012-bib-0132"><label>132</label><mixed-citation publication-type="journal" id="imm13012-cit-0132">
<string-name>
<surname>Plotkin</surname>
<given-names>SA</given-names>
</string-name>. <article-title>Complex correlates of protection after vaccination</article-title>. <source xml:lang="en">Clin Infect Dis</source>
<year>2013</year>; <volume>56</volume>:<fpage>1458</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="pmid">23386629</pub-id></mixed-citation></ref><ref id="imm13012-bib-0133"><label>133</label><mixed-citation publication-type="journal" id="imm13012-cit-0133">
<string-name>
<surname>Obermoser</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Presnell</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Domico</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Anguiano</surname>
<given-names>E</given-names>
</string-name>
<italic>et al</italic>
<article-title>Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines</article-title>. <source xml:lang="en">Immunity</source>
<year>2013</year>; <volume>38</volume>:<fpage>831</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="pmid">23601689</pub-id></mixed-citation></ref><ref id="imm13012-bib-0134"><label>134</label><mixed-citation publication-type="journal" id="imm13012-cit-0134">
<string-name>
<surname>Haks</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Bottazzi</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Cecchinato</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>De Gregorio</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Del Giudice</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Kaufmann</surname>
<given-names>SHE</given-names>
</string-name>
<italic>et al</italic>
<article-title>Molecular signatures of immunity and immunogenicity in infection and vaccination</article-title>. <source xml:lang="en">Front Immunol</source>
<year>2017</year>; <volume>8</volume>:<fpage>1563</fpage>.<pub-id pub-id-type="pmid">29204145</pub-id></mixed-citation></ref><ref id="imm13012-bib-0135"><label>135</label><mixed-citation publication-type="journal" id="imm13012-cit-0135">
<string-name>
<surname>Joosten</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Goeman</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Sutherland</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Opmeer</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>de Boer</surname>
<given-names>KG</given-names>
</string-name>, <string-name>
<surname>Jacobsen</surname>
<given-names>M</given-names>
</string-name>
<italic>et al</italic>
<article-title>Identification of biomarkers for tuberculosis disease using a novel dual&#x02010;color RT&#x02010;MLPA assay</article-title>. <source xml:lang="en">Genes Immun</source>
<year>2012</year>; <volume>13</volume>:<fpage>71</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="pmid">21956656</pub-id></mixed-citation></ref><ref id="imm13012-bib-0136"><label>136</label><mixed-citation publication-type="journal" id="imm13012-cit-0136">
<string-name>
<surname>Loxton</surname>
<given-names>AG</given-names>
</string-name>, <string-name>
<surname>Knaul</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Grode</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Gutschmidt</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Meller</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Eisele</surname>
<given-names>B</given-names>
</string-name>
<italic>et al</italic>
<article-title>Safety and immunogenicity of the recombinant <italic>Mycobacterium bovis</italic> BCG vaccine VPM1002 in HIV&#x02010;unexposed newborn infants in South Africa</article-title>. <source xml:lang="en">Clin Vaccine Immunol</source>
<year>2017</year>; <volume>24</volume>:<fpage>pii: e00439&#x02010;16</fpage>.</mixed-citation></ref><ref id="imm13012-bib-0137"><label>137</label><mixed-citation publication-type="journal" id="imm13012-cit-0137">
<string-name>
<surname>Olin</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Henckel</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Lakshmikanth</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Pou</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Mikes</surname>
<given-names>J</given-names>
</string-name>
<italic>et al</italic>
<article-title>Stereotypic immune system development in newborn children</article-title>. <source xml:lang="en">Cell</source>
<year>2018</year>; <volume>174</volume>:<fpage>1277</fpage>&#x02013;<lpage>92</lpage>. e1214.<pub-id pub-id-type="pmid">30142345</pub-id></mixed-citation></ref><ref id="imm13012-bib-0138"><label>138</label><mixed-citation publication-type="journal" id="imm13012-cit-0138">
<string-name>
<surname>Jennewein</surname>
<given-names>MF</given-names>
</string-name>, <string-name>
<surname>Butler</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Alter</surname>
<given-names>G</given-names>
</string-name>. <article-title>Neonate&#x02010;omics: charting the unknown immune response in early life</article-title>. <source xml:lang="en">Cell</source>
<year>2018</year>; <volume>174</volume>:<fpage>1051</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="pmid">30142343</pub-id></mixed-citation></ref><ref id="imm13012-bib-0139"><label>139</label><mixed-citation publication-type="journal" id="imm13012-cit-0139">
<string-name>
<surname>Delhalle</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bode</surname>
<given-names>SFN</given-names>
</string-name>, <string-name>
<surname>Balling</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ollert</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>FQ</given-names>
</string-name>. <article-title>A roadmap towards personalized immunology</article-title>. <source xml:lang="en">NPJ Syst Biol Appl</source>
<year>2018</year>; <volume>4</volume>:<fpage>9</fpage>.<pub-id pub-id-type="pmid">29423275</pub-id></mixed-citation></ref><ref id="imm13012-bib-0140"><label>140</label><mixed-citation publication-type="journal" id="imm13012-cit-0140">
<string-name>
<surname>Pulendran</surname>
<given-names>B</given-names>
</string-name>. <article-title>Systems vaccinology: probing humanity's diverse immune systems with vaccines</article-title>. <source xml:lang="en">Proc Natl Acad Sci U S A</source>
<year>2014</year>; <volume>111</volume>:<fpage>12300</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">25136102</pub-id></mixed-citation></ref><ref id="imm13012-bib-0141"><label>141</label><mixed-citation publication-type="journal" id="imm13012-cit-0141">
<string-name>
<surname>de Bree</surname>
<given-names>LCJ</given-names>
</string-name>, <string-name>
<surname>Koeken</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Joosten</surname>
<given-names>LAB</given-names>
</string-name>, <string-name>
<surname>Aaby</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Benn</surname>
<given-names>CS</given-names>
</string-name>, <string-name>
<surname>van Crevel</surname>
<given-names>R</given-names>
</string-name>
<italic>et al</italic>
<article-title>Non&#x02010;specific effects of vaccines: current evidence and potential implications</article-title>. <source xml:lang="en">Semin Immunol</source>
<year>2018</year>; pii: S1044&#x02010;5323(18)30011&#x02010;3. <pub-id pub-id-type="doi">10.1016/j.smim.2018.06.002</pub-id>. [Epub ahead of print]</mixed-citation></ref><ref id="imm13012-bib-0142"><label>142</label><mixed-citation publication-type="journal" id="imm13012-cit-0142">
<string-name>
<surname>Seib</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>Dougan</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Rappuoli</surname>
<given-names>R</given-names>
</string-name>. <article-title>The key role of genomics in modern vaccine and drug design for emerging infectious diseases</article-title>. <source xml:lang="en">PLoS Genet</source>
<year>2009</year>; <volume>5</volume>:<fpage>e1000612</fpage>.<pub-id pub-id-type="pmid">19855822</pub-id></mixed-citation></ref><ref id="imm13012-bib-0143"><label>143</label><mixed-citation publication-type="journal" id="imm13012-cit-0143">
<string-name>
<surname>Grover</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sharma</surname>
<given-names>PC</given-names>
</string-name>. <article-title>Development and use of molecular markers: past and present</article-title>. <source xml:lang="en">Crit Rev Biotechnol</source>
<year>2016</year>; <volume>36</volume>:<fpage>290</fpage>&#x02013;<lpage>302</lpage>.<pub-id pub-id-type="pmid">25430893</pub-id></mixed-citation></ref><ref id="imm13012-bib-0144"><label>144</label><mixed-citation publication-type="journal" id="imm13012-cit-0144">
<string-name>
<surname>Ovsyannikova</surname>
<given-names>IG</given-names>
</string-name>, <string-name>
<surname>Salk</surname>
<given-names>HM</given-names>
</string-name>, <string-name>
<surname>Larrabee</surname>
<given-names>BR</given-names>
</string-name>, <string-name>
<surname>Pankratz</surname>
<given-names>VS</given-names>
</string-name>, <string-name>
<surname>Poland</surname>
<given-names>GA</given-names>
</string-name>. <article-title>Single&#x02010;nucleotide polymorphism associations in common with immune responses to measles and rubella vaccines</article-title>. <source xml:lang="en">Immunogenetics</source>
<year>2014</year>; <volume>66</volume>:<fpage>663</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">25139337</pub-id></mixed-citation></ref><ref id="imm13012-bib-0145"><label>145</label><mixed-citation publication-type="journal" id="imm13012-cit-0145">
<string-name>
<surname>Linnik</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Egli</surname>
<given-names>A</given-names>
</string-name>. <article-title>Impact of host genetic polymorphisms on vaccine induced antibody response</article-title>. <source xml:lang="en">Hum Vaccin Immunother</source>
<year>2016</year>; <volume>12</volume>:<fpage>907</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="pmid">26809773</pub-id></mixed-citation></ref><ref id="imm13012-bib-0146"><label>146</label><mixed-citation publication-type="journal" id="imm13012-cit-0146">
<string-name>
<surname>Tserel</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Kolde</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Limbach</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tretyakov</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kasela</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kisand</surname>
<given-names>K</given-names>
</string-name>
<italic>et al</italic>
<article-title>Age&#x02010;related profiling of DNA methylation in CD8<sup>+</sup> T cells reveals changes in immune response and transcriptional regulator genes</article-title>. <source xml:lang="en">Sci Rep</source>
<year>2015</year>; <volume>5</volume>:<fpage>13107</fpage>.<pub-id pub-id-type="pmid">26286994</pub-id></mixed-citation></ref><ref id="imm13012-bib-0147"><label>147</label><mixed-citation publication-type="journal" id="imm13012-cit-0147">
<string-name>
<surname>Zimmermann</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Oberg</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Grill</surname>
<given-names>DE</given-names>
</string-name>, <string-name>
<surname>Ovsyannikova</surname>
<given-names>IG</given-names>
</string-name>, <string-name>
<surname>Haralambieva</surname>
<given-names>IH</given-names>
</string-name>, <string-name>
<surname>Kennedy</surname>
<given-names>RB</given-names>
</string-name>
<italic>et al</italic>
<article-title>System&#x02010;wide associations between DNA&#x02010;methylation, gene expression, and humoral immune response to influenza vaccination</article-title>. <source xml:lang="en">PLoS ONE</source>
<year>2016</year>; <volume>11</volume>:<fpage>e0152034</fpage>.<pub-id pub-id-type="pmid">27031986</pub-id></mixed-citation></ref><ref id="imm13012-bib-0148"><label>148</label><mixed-citation publication-type="journal" id="imm13012-cit-0148">
<string-name>
<surname>Youngblood</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Hale</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Akondy</surname>
<given-names>R</given-names>
</string-name>. <article-title>Using epigenetics to define vaccine&#x02010;induced memory T cells</article-title>. <source xml:lang="en">Curr Opin Virol</source>
<year>2013</year>; <volume>3</volume>:<fpage>371</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">23747121</pub-id></mixed-citation></ref><ref id="imm13012-bib-0149"><label>149</label><mixed-citation publication-type="journal" id="imm13012-cit-0149">
<string-name>
<surname>Poland</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Ovsyannikova</surname>
<given-names>IG</given-names>
</string-name>, <string-name>
<surname>Kennedy</surname>
<given-names>RB</given-names>
</string-name>. <article-title>Personalized vaccinology: a review</article-title>. <source xml:lang="en">Vaccine</source>
<year>2018</year>; <volume>36</volume>:<fpage>5350</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">28774561</pub-id></mixed-citation></ref><ref id="imm13012-bib-0150"><label>150</label><mixed-citation publication-type="journal" id="imm13012-cit-0150">
<string-name>
<surname>Poland</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Kennedy</surname>
<given-names>RB</given-names>
</string-name>, <string-name>
<surname>McKinney</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Ovsyannikova</surname>
<given-names>IG</given-names>
</string-name>, <string-name>
<surname>Lambert</surname>
<given-names>ND</given-names>
</string-name>, <string-name>
<surname>Jacobson</surname>
<given-names>RM</given-names>
</string-name>
<italic>et al</italic>
<article-title>Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century</article-title>. <source xml:lang="en">Semin Immunol</source>
<year>2013</year>; <volume>25</volume>:<fpage>89</fpage>&#x02013;<lpage>103</lpage>.<pub-id pub-id-type="pmid">23755893</pub-id></mixed-citation></ref><ref id="imm13012-bib-0151"><label>151</label><mixed-citation publication-type="journal" id="imm13012-cit-0151">
<string-name>
<surname>Castiblanco</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Anaya</surname>
<given-names>JM</given-names>
</string-name>. <article-title>Genetics and vaccines in the era of personalized medicine</article-title>. <source xml:lang="en">Curr Genomics</source>
<year>2015</year>; <volume>16</volume>:<fpage>47</fpage>&#x02013;<lpage>59</lpage>.<pub-id pub-id-type="pmid">25937813</pub-id></mixed-citation></ref><ref id="imm13012-bib-0152"><label>152</label><mixed-citation publication-type="journal" id="imm13012-cit-0152">
<string-name>
<surname>Lowe</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Shirley</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Bleackley</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Dolan</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Shafee</surname>
<given-names>T</given-names>
</string-name>. <article-title>Transcriptomics technologies</article-title>. <source xml:lang="en">PLoS Comput Biol</source>
<year>2017</year>; <volume>13</volume>:<fpage>e1005457</fpage>.<pub-id pub-id-type="pmid">28545146</pub-id></mixed-citation></ref><ref id="imm13012-bib-0153"><label>153</label><mixed-citation publication-type="journal" id="imm13012-cit-0153">
<string-name>
<surname>Barton</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Hill</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Pollard</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Blohmke</surname>
<given-names>CJ</given-names>
</string-name>. <article-title>Transcriptomics in human challenge models</article-title>. <source xml:lang="en">Front Immunol</source>
<year>2017</year>; <volume>8</volume>:<fpage>1839</fpage>.<pub-id pub-id-type="pmid">29326715</pub-id></mixed-citation></ref><ref id="imm13012-bib-0154"><label>154</label><mixed-citation publication-type="journal" id="imm13012-cit-0154">
<string-name>
<surname>Bakken</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Cowell</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Aevermann</surname>
<given-names>BD</given-names>
</string-name>, <string-name>
<surname>Novotny</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hodge</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Miller</surname>
<given-names>JA</given-names>
</string-name>
<italic>et al</italic>
<article-title>Cell type discovery and representation in the era of high&#x02010;content single cell phenotyping</article-title>. <source xml:lang="en">BMC Bioinformatics</source>
<year>2017</year>; <volume>18</volume>(<issue>Suppl 17</issue>):<fpage>559</fpage>.<pub-id pub-id-type="pmid">29322913</pub-id></mixed-citation></ref><ref id="imm13012-bib-0155"><label>155</label><mixed-citation publication-type="journal" id="imm13012-cit-0155">
<string-name>
<surname>Westermann</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Vogel</surname>
<given-names>J</given-names>
</string-name>. <article-title>Host&#x02010;pathogen transcriptomics by dual RNA&#x02010;Seq</article-title>. <source xml:lang="en">Methods Mol Biol</source>
<year>2018</year>; <volume>1737</volume>:<fpage>59</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="pmid">29484587</pub-id></mixed-citation></ref><ref id="imm13012-bib-0156"><label>156</label><mixed-citation publication-type="journal" id="imm13012-cit-0156">
<string-name>
<surname>Westermann</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Barquist</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Vogel</surname>
<given-names>J</given-names>
</string-name>. <article-title>Resolving host&#x02013;pathogen interactions by dual RNA&#x02010;seq</article-title>. <source xml:lang="en">PLoS Pathog</source>
<year>2017</year>; <volume>13</volume>:<fpage>e1006033</fpage>.<pub-id pub-id-type="pmid">28207848</pub-id></mixed-citation></ref><ref id="imm13012-bib-0157"><label>157</label><mixed-citation publication-type="journal" id="imm13012-cit-0157">
<string-name>
<surname>Ontoria</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Hernandez&#x02010;Santana</surname>
<given-names>YE</given-names>
</string-name>, <string-name>
<surname>Gonzalez&#x02010;Garcia</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Lopez</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Valladares</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Carmelo</surname>
<given-names>E</given-names>
</string-name>. <article-title>Transcriptional profiling of immune&#x02010;related genes in <italic>Leishmania infantum</italic>&#x02010;infected mice: identification of potential biomarkers of infection and progression of disease</article-title>. <source xml:lang="en">Front Cell Infect Microbiol</source>
<year>2018</year>; <volume>8</volume>:<fpage>197</fpage>.<pub-id pub-id-type="pmid">30013952</pub-id></mixed-citation></ref><ref id="imm13012-bib-0158"><label>158</label><mixed-citation publication-type="journal" id="imm13012-cit-0158">
<string-name>
<surname>Sharon</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Rynkiewicz</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>CY</given-names>
</string-name>. <article-title>Discovery of protective B&#x02010;cell epitopes for development of antimicrobial vaccines and antibody therapeutics</article-title>. <source xml:lang="en">Immunology</source>
<year>2014</year>; <volume>142</volume>:<fpage>1</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="pmid">24219801</pub-id></mixed-citation></ref><ref id="imm13012-bib-0159"><label>159</label><mixed-citation publication-type="journal" id="imm13012-cit-0159">
<string-name>
<surname>Behrendt</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Pradzinska</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Spodzieja</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kolodziejczyk</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Rodziewicz&#x02010;Motowidlo</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Szymanska</surname>
<given-names>A</given-names>
</string-name>
<italic>et al</italic>
<article-title>Epitope location for two monoclonal antibodies against human cystatin C, representing opposite aggregation inhibitory properties</article-title>. <source xml:lang="en">Amino Acids</source>
<year>2016</year>; <volume>48</volume>:<fpage>1717</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="pmid">27143169</pub-id></mixed-citation></ref><ref id="imm13012-bib-0160"><label>160</label><mixed-citation publication-type="journal" id="imm13012-cit-0160">
<string-name>
<surname>Hager&#x02010;Braun</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Tomer</surname>
<given-names>KB</given-names>
</string-name>. <article-title>Determination of protein&#x02010;derived epitopes by mass spectrometry</article-title>. <source xml:lang="en">Expert Rev Proteomics</source>
<year>2005</year>; <volume>2</volume>:<fpage>745</fpage>&#x02013;<lpage>56</lpage>.<pub-id pub-id-type="pmid">16209653</pub-id></mixed-citation></ref><ref id="imm13012-bib-0161"><label>161</label><mixed-citation publication-type="journal" id="imm13012-cit-0161">
<string-name>
<surname>Vaughan</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Caron</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Peters</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Sette</surname>
<given-names>A</given-names>
</string-name>. <article-title>Deciphering the MHC&#x02010;associated peptidome: a review of naturally processed ligand data</article-title>. <source xml:lang="en">Expert Rev Proteomics</source>
<year>2017</year>; <volume>14</volume>:<fpage>729</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="pmid">28756714</pub-id></mixed-citation></ref><ref id="imm13012-bib-0162"><label>162</label><mixed-citation publication-type="journal" id="imm13012-cit-0162">
<string-name>
<surname>Weiner</surname>
<given-names>J</given-names>
<suffix>3rd</suffix>
</string-name>, <string-name>
<surname>Mohney</surname>
<given-names>RP</given-names>
</string-name>, <string-name>
<surname>Kaufmann</surname>
<given-names>SHE</given-names>
</string-name>. <article-title>The potential of metabolic profiling for vaccine development</article-title>. <source xml:lang="en">Semin Immunol</source>
<year>2018</year>; pii: S1044&#x02010;5323(18)30027&#x02010;7. <pub-id pub-id-type="doi">10.1016/j.smim.2018.07.002</pub-id>.</mixed-citation></ref><ref id="imm13012-bib-0163"><label>163</label><mixed-citation publication-type="journal" id="imm13012-cit-0163">
<string-name>
<surname>Gardinassi</surname>
<given-names>LG</given-names>
</string-name>, <string-name>
<surname>Arevalo&#x02010;Herrera</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Herrera</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Cordy</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Tran</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>MR</given-names>
</string-name>
<italic>et al</italic>
<article-title>Integrative metabolomics and transcriptomics signatures of clinical tolerance to <italic>Plasmodium vivax</italic> reveal activation of innate cell immunity and T cell signaling</article-title>. <source xml:lang="en">Redox Biol</source>
<year>2018</year>; <volume>17</volume>:<fpage>158</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">29698924</pub-id></mixed-citation></ref><ref id="imm13012-bib-0164"><label>164</label><mixed-citation publication-type="journal" id="imm13012-cit-0164">
<string-name>
<surname>Wood</surname>
<given-names>PL</given-names>
</string-name>, <string-name>
<surname>Steinman</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Erol</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Carter</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Christmann</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Verma</surname>
<given-names>A</given-names>
</string-name>. <article-title>Lipidomic analysis of immune activation in equine leptospirosis and <italic>Leptospira</italic>&#x02010;vaccinated horses</article-title>. <source xml:lang="en">PLoS ONE</source>
<year>2018</year>; <volume>13</volume>:<fpage>e0193424</fpage>.<pub-id pub-id-type="pmid">29474474</pub-id></mixed-citation></ref><ref id="imm13012-bib-0165"><label>165</label><mixed-citation publication-type="journal" id="imm13012-cit-0165">
<string-name>
<surname>Tisoncik&#x02010;Go</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gasper</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Kyle</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Eisfeld</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Selinger</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Hatta</surname>
<given-names>M</given-names>
</string-name>
<italic>et al</italic>
<article-title>Integrated omics analysis of pathogenic host responses during pandemic H1N1 influenza virus infection: the crucial role of lipid metabolism</article-title>. <source xml:lang="en">Cell Host Microbe</source>
<year>2016</year>; <volume>19</volume>:<fpage>254</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="pmid">26867183</pub-id></mixed-citation></ref><ref id="imm13012-bib-0166"><label>166</label><mixed-citation publication-type="journal" id="imm13012-cit-0166">
<string-name>
<surname>Mahan</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Tedesco</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Dionne</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Baruah</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Cheng</surname>
<given-names>HD</given-names>
</string-name>, <string-name>
<surname>De Jager</surname>
<given-names>PL</given-names>
</string-name>
<italic>et al</italic>
<article-title>A method for high&#x02010;throughput, sensitive analysis of IgG Fc and Fab glycosylation by capillary electrophoresis</article-title>. <source xml:lang="en">J Immunol Methods</source>
<year>2015</year>; <volume>417</volume>:<fpage>34</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="pmid">25523925</pub-id></mixed-citation></ref><ref id="imm13012-bib-0167"><label>167</label><mixed-citation publication-type="journal" id="imm13012-cit-0167">
<string-name>
<surname>Harris</surname>
<given-names>VC</given-names>
</string-name>, <string-name>
<surname>Haak</surname>
<given-names>BW</given-names>
</string-name>, <string-name>
<surname>Handley</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Velasquez</surname>
<given-names>DE</given-names>
</string-name>, <string-name>
<surname>Hykes</surname>
<given-names>BL</given-names>
<suffix>Jr</suffix>
</string-name>
<italic>et al</italic>
<article-title>Effect of antibiotic&#x02010;mediated microbiome modulation on rotavirus vaccine immunogenicity: a human, randomized&#x02010;control proof&#x02010;of&#x02010;concept trial</article-title>. <source xml:lang="en">Cell Host Microbe</source>
<year>2018</year>; <volume>24</volume>:<fpage>197</fpage>&#x02013;<lpage>207</lpage>. e194.<pub-id pub-id-type="pmid">30092197</pub-id></mixed-citation></ref><ref id="imm13012-bib-0168"><label>168</label><mixed-citation publication-type="journal" id="imm13012-cit-0168">
<string-name>
<surname>Barrila</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Crabbe</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Franco</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Nydam</surname>
<given-names>SD</given-names>
</string-name>, <string-name>
<surname>Forsyth</surname>
<given-names>RJ</given-names>
</string-name>
<italic>et al</italic>
<article-title>Modeling host&#x02013;pathogen interactions in the context of the microenvironment: 3&#x02010;D cell culture comes of age</article-title>. <source xml:lang="en">Infect Immun</source>
<year>2018</year>; <volume>86</volume> (<issue>11</issue>) <fpage>e00282</fpage>&#x02013;<lpage>18</lpage>; <pub-id pub-id-type="doi">10.1128/IAI.00282-18</pub-id>
<pub-id pub-id-type="pmid">30181350</pub-id></mixed-citation></ref><ref id="imm13012-bib-0169"><label>169</label><mixed-citation publication-type="journal" id="imm13012-cit-0169">
<string-name>
<surname>Harris</surname>
<given-names>VC</given-names>
</string-name>. <article-title>The significance of the intestinal microbiome for vaccinology: from correlations to therapeutic applications</article-title>. <source xml:lang="en">Drugs</source>
<year>2018</year>; <volume>78</volume>:<fpage>1063</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="pmid">29943376</pub-id></mixed-citation></ref><ref id="imm13012-bib-0170"><label>170</label><mixed-citation publication-type="journal" id="imm13012-cit-0170">
<string-name>
<surname>Knight</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Vrbanac</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Taylor</surname>
<given-names>BC</given-names>
</string-name>, <string-name>
<surname>Aksenov</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Callewaert</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Debelius</surname>
<given-names>J</given-names>
</string-name>
<italic>et al</italic>
<article-title>Best practices for analysing microbiomes</article-title>. <source xml:lang="en">Nat Rev Microbiol</source>
<year>2018</year>; <volume>16</volume>:<fpage>410</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">29795328</pub-id></mixed-citation></ref><ref id="imm13012-bib-0171"><label>171</label><mixed-citation publication-type="journal" id="imm13012-cit-0171">
<string-name>
<surname>Marsland</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Gollwitzer</surname>
<given-names>ES</given-names>
</string-name>. <article-title>Host&#x02013;microorganism interactions in lung diseases</article-title>. <source xml:lang="en">Nat Rev Immunol</source>
<year>2014</year>; <volume>14</volume>:<fpage>827</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="pmid">25421702</pub-id></mixed-citation></ref><ref id="imm13012-bib-0172"><label>172</label><mixed-citation publication-type="journal" id="imm13012-cit-0172">
<string-name>
<surname>Rooks</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Garrett</surname>
<given-names>WS</given-names>
</string-name>. <article-title>Gut microbiota, metabolites and host immunity</article-title>. <source xml:lang="en">Nat Rev Immunol</source>
<year>2016</year>; <volume>16</volume>:<fpage>341</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="pmid">27231050</pub-id></mixed-citation></ref><ref id="imm13012-bib-0173"><label>173</label><mixed-citation publication-type="journal" id="imm13012-cit-0173">
<string-name>
<surname>Schnupf</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Gaboriau&#x02010;Routhiau</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Cerf&#x02010;Bensussan</surname>
<given-names>N</given-names>
</string-name>. <article-title>Modulation of the gut microbiota to improve innate resistance</article-title>. <source xml:lang="en">Curr Opin Immunol</source>
<year>2018</year>; <volume>54</volume>:<fpage>137</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="pmid">30205357</pub-id></mixed-citation></ref><ref id="imm13012-bib-0174"><label>174</label><mixed-citation publication-type="journal" id="imm13012-cit-0174">
<string-name>
<surname>Zimmermann</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Curtis</surname>
<given-names>N</given-names>
</string-name>. <article-title>The influence of the intestinal microbiome on vaccine responses</article-title>. <source xml:lang="en">Vaccine</source>
<year>2018</year>; <volume>36</volume>:<fpage>4433</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">29909134</pub-id></mixed-citation></ref><ref id="imm13012-bib-0175"><label>175</label><mixed-citation publication-type="journal" id="imm13012-cit-0175">
<string-name>
<surname>Furman</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Jojic</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Kidd</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Shen&#x02010;Orr</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Price</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Jarrell</surname>
<given-names>J</given-names>
</string-name>
<italic>et al</italic>
<article-title>Apoptosis and other immune biomarkers predict influenza vaccine responsiveness</article-title>. <source xml:lang="en">Mol Syst Biol</source>
<year>2013</year>; <volume>9</volume>:<fpage>659</fpage>.<pub-id pub-id-type="pmid">23591775</pub-id></mixed-citation></ref><ref id="imm13012-bib-0176"><label>176</label><mixed-citation publication-type="journal" id="imm13012-cit-0176">
<string-name>
<surname>Bucasas</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>Franco</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Shaw</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Bray</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Wells</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Nino</surname>
<given-names>D</given-names>
</string-name>
<italic>et al</italic>
<article-title>Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humans</article-title>. <source xml:lang="en">J Infect Dis</source>
<year>2011</year>; <volume>203</volume>:<fpage>921</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">21357945</pub-id></mixed-citation></ref></ref-list></back></article>